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Herbal medicine is gaining world wide popularity. The rapid increase in usage of herbal 
medicine has important medical and socio-economic implications. Assessment of the 
safety, quality and efficacy of herbal medicines becomes an important issue.  
In this study, HPLC and LC-MS methods for the analysis of complex mixtures of 
botanical origins are developed. A rapid and sensitive HPLC method for the detection of 
4 biologically active chemical markers in Gastrodia elata, namely, gastrodin, 4-
hydroxbenzyl alcohol and 4-hydroxybenzaldehyde and L-pyroglutamic acid has been 
successfully developed.  To the author’s knowledge, this is the first report of 
simultaneous detection of 4 active constituents in this medicinal plant. The contents of 
gastrodin, which is the main active ingredient, has also been determined in the plant and 
in the products (Chinese Proprietary Medicine, i.e. CPM). This method has been 
validated for linearity, precision, accuracy, LOD and LOQ. For the CPM, the presence of 
other plants further complicates the complex herbal matrix, resulting in the gastrodin 
peak being co-eluted with other herbal ingredients. Hence a SPE sample cleanup method 
is successfully developed and employed. 
In many medicinal plants, the active constituents may not be known. HPLC 
chromatographic fingerprinting can be used for quality control of herbal medicines, 
especially when the marker compounds are not available or not known. In the present 
work, a HPLC chromatographic fingerprinting method is successfully developed and 
applied to 34 botanical samples, constituting 11 different types of herbal medicines. 
 VIII
Hierarchical analysis of the resulting chromatograms is performed. Results show that 
most of the Fangji samples in Singapore resemble the toxic Guangfangji samples. 
Successful differentiation between Fangji (Stephania tetrandra) and Guangfangji (A. 
fangchi) is achieved and results are confirmed by LC-MS/MS. This is the first report of 
comparative LC-MS/MS study of these two commonly mistaken herbs. This study 
indicates the urgent need for more stringent quality control of herbal medicine.  
Analysis of complex mixtures of botanical origins is very challenging. The work 
presented in this thesis has clearly demonstrated that methods for the analysis of some 
commonly used herbs in Singapore and around the region, have been developed and have 
been shown to be useful for the quality control of such botanicals and their products. The 
methods developed can be extended to other complex mixtures of botanical origins with 
appropriate optimization, when necessary. Academics/researchers, health professionals, 
consumers, regulators and people from industries must work together to ensure the safety 
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1.1 Importance of herbal medicines 
Over the past decades, herbal medicines have become a topic of increasing global 
importance, with both medical and economic implications (WHO, 1998a; Tyler, 1999).  
In many developing countries, herbal medicines have always played a central role in 
healthcare. Although modern medicine may be available in these countries, it is estimated 
that 65 to 80% of the populations depend on traditional medicines as the primary source 
of healthcare (Bannerman et al, 1983). In many circumstances, herbal medicines may be 
the only medicine available to populations in developing nations, due to the fact that 
modern pharmaceutical drugs are in great demand and are costly.  
Historically, all medical systems, including the medical system in developed countries, 
were once botanically based. In fact, herbal medicines were practiced worldwide 
relatively successfully before the advent of new synthetic drugs. Due to a lack of clinical 
data to establish the safety and efficacy of herbal medicine, the use of herbal medicines 
declined in the developed countries only during the 1940s to 1950s (Gail et al, 2001). In 
Herbal medicines are plant-derived materials or preparations with therapeutic or 
other human health benefits which contains either raw or processed ingredients 
from one or more plants. In some traditions materials of inorganic or animal 
origin may also be present (WHO, 1998).  
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recent years, the usage of complementary and alternative medicine (CAM), including 
herbal medicine, has increased (Koh et al, 2003 and Eisenberg et al, 1998). It has also 
been estimated that about 25% of all prescription drugs are derived either directly or 
indirectly from natural sources such as plants, bacteria, and fungi (Farnsworth and Morris, 
1976; WHO, 2002).  
In developed countries, including Australia, Canada, Europe and the United States, a 
resurgence of interest in herbal medicines has resulted from the preference of many 
consumers for products of natural origin. In the U.S. alone, it is estimated that herbal 
usage increased by 380%, in the period between 1990 and 1997 (Eisenberg et al, 1998). 
According to WHO report (2002a), in USA, herbal sales increased by 101%, from US$ 
292 million to US$ 587 million in mainstream markets between May 1996 and May 1998. 
This herbal renaissance has been fueled by strong consumer interest in natural therapies, 
preventative medicine, coupled with a disappointment with allopathic medicine, and the 
perception that herbal medicines are relatively safe and free from side effects. In France, 
75% of the population has used complementary medicine at least once. In German, 77% 
of pain clinics provide acupuncture. In the United Kingdom, expenditure on 
complementary or alternative medicine stands at US$ 2.3 billion per year (WHO, 2002). 
In Australia, research has indicated that 48.5% of the population used at least one non–
medically prescribed alternative medicine in 1993. The estimated national expenditure on 
alternative medicines and alternative practitioners is close to A$1 000 million per annum, 
of which A$621 million is spent on alternative medicines (Maclennan, et al, 1996). An 
Australian government report in 1996 estimated that there were at least 2.8 million 
traditional Chinese medicine consultations in 1996, representing an annual turnover of 
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A$84 million within the health economy. This growth was also reflected in a four–fold 
increase in the importation of Chinese herbal medicines since 1992 (WHO, 2000). 
The world market for herbal medicines based on traditional knowledge was estimated at 
US$ 60 billion a year, some 20 percent of the overall drug market (WHO, 2002a). In 
China, Traditional Chinese Medicine is fully integrated into China’s health system. 95% 
of Chinese hospitals have units for traditional medicine (WHO, 2002). Over 100 
thousand herbal preparations have been recorded that are still in clinical use (WHO, 
2000). Traditional medicine accounts for 30-50% of total consumption. There are 800 
manufacturers of herbal products with a total annual output of US$ 1.8 billion (WHO, 
2002).  
In 2000, the herbal medicine market in Japan was worth US$ 2.4 billion. An October 
2000 survey showed that 72% of registered western-style doctors use kampo medicine 
(the Japanese adaptation of Chinese medicine) in their clinical services (WHO, 2002). A 
study conducted in Tokyo in 1990 showed that 91% of the survey population considered 
that oriental medicine was effective for chronic diseases, 49% had used herbal medicines. 
Japan now produces 210 Kampo herbal formulas according to strict quality controls, 147 
of which are covered by health insurance (WHO, 2000). 
In Singapore, some people make use of herbal medicines as their alternative form of 
healthcare. A report (Singapore, 1995) by a review committee on Traditional Chinese 
Medicine showed that about 45% of Singaporeans had consulted Traditional Chinese 
Medicine practitioners in the past. A much smaller proportion of Malays (8%) and 
Indians (16%) had also consulted a Traditional Chinese Medicine practitioner. About 
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12% of daily outpatient attendance is estimated to be seen by Traditional Chinese 
Medicine Practitioners. It is estimated that there are about 8000 to 10000 CPM products 
in the market. They are readily available in the medical halls, supermarkets, and 
pharmacies etc. The number of Chinese medical halls that are registered with Registry of 
Companies and Businesses is estimated to be 900. 
1.2 An increasing need for quality control of herbal medicines 
With the tremendous expansion in the use of herbal medicines worldwide, assurance of 
their quality, safety and efficacy have become an important concern for both health 
authorities and the public (Gail et al, 2001; Koh and Woo, 2000). For instance, the herb 
Ma Huang (ephedra) is traditionally used in China to treat short-term respiratory 
congestion. In the United States, the herb was marketed as a dietary aid, whose long-term 
use led to at least a dozen deaths, heart attacks and strokes. The U.S. Food and Drug 
Administration (2003) issued a consumer alert on the safety of dietary supplements 
containing ephedra. In Belgium, at least 70 people required renal transplant or dialysis for 
interstitial fibrosis of the kidney after taking the wrong herb from the Aristolochiaceae 
family, again as a dietary aid (Vanherwegnem et al, 1993). 
Unlike conventional drugs, herbal medicines present some unique problems in their 
quality standardization. These variables are caused by many factors such as species 
difference, organ specificity, seasonal variation, cultivation, harvest, storage, 
transportation, adulteration, substitution, contamination, post harvest treatment and 
manufacturing practices (Eskinazi, et al, 1999). Therefore, product variation in herbal 
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medicines can be significant. For example, the content of ginsenosides was examined in 
50 commercial brands of ginseng sold in 11 countries (Cui et al, 1994). In forty-four of 
these products, the concentration of ginsenosides ranged from 1.9% to 9% (w/w); 6 
products contained no ginsenosides and one of these contained large amounts of 
ephedrine.  
To guarantee batch-to-batch reproducibility of plant material and herbal products, 
standardization of herbal medicine is necessary. Active components of herbal medicines 
are often used as markers for quality control of herbal medicine (Thompson and Morris, 
2001).  
1.3 Analytical methods for quality control of herbal medicines 
Quality control directly impacts the safety and efficacy of herbal medicines (WHO, 2003). 
The entire process of product of herbal medicines, from raw materials to finished herbal 
products, need to be controlled. World Health Organization has developed a series of 
technical guidelines relating to the quality control of herbal medicines. These include: 
Guidelines for the assessment of herbal medicines (WHO, 1991), Good manufacturing 
practice (GMP): supplementary guidelines for the manufacture of herbal medicinal 
products (WHO, 1996), and Guidelines on good agricultural and collection practices 
[GACP] for medicinal plants (WHO, 2003). 
“Markers” was defined by WHO (1996) as “constituents of medicinal plant material 
which are chemically defined and of interest for control purposes”. Analysis of maker 
compounds in herbal medicines can be accomplished by colorimetric, spectroscopic or 
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chromatographic methods (Gail et al, 2001). Colorimetric and spectroscopic methods are 
older analytical procedures quantifying the absorption of structurally related compounds 
at a specific wavelength of light, and expressed as concentration of a reference compound, 
which is normally the active or major chemical constituent in that plant material. Since 
other unrelated plant constituents absorbing at the same wavelength will also be included 
in the measurement, a higher concentration can be erroneously ascribed to the test. There 
has been a decline in the use of these procedures in recent years (Gail et al, 2001). 
In recent years, chromatographic procedures have become the method of choice for the 
analysis of secondary chemical constituents. Thin-layer chromatographic (TLC) 
procedures have the advantage of being simple, rapid, can provide useful characteristic 
profile patterns, and are inexpensive to use (Wagner and Bladt, 1996). However, their 
resolving power is limited. Gas chromatography (GC) can provide high resolution of the 
more volatile complex mixtures, but is of limited value in the case of non-volatile polar 
compounds, especially the polar polyhydroxylated and glycosidic compounds (Gail et al, 
2001). High-performance liquid chromatography (HPLC) is capable of resolving 
complex mixtures of polar and non-polar compounds, and has become the method of 
choice for the qualitative and quantitative analysis of herbal extracts and products. The 
use of liquid chromatography-mass spectrometry (LC-MS) and liquid chromatography - 
mass spectrometry - mass spectrometry (LC-MS/MS) has rapidly increased in the last 
few years. In the past decade, the development of simple, reliable, LC/MS interfaces, 
most notably electrospray (ESI) and atmospheric pressure chemical ionization (APCI), 
has spurred the development and acceptance of LC/MS methods, such that, today, there 
are many laboratories that routinely use LC/MS as the primary analytical method (Tiller 
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et al, 2003; Hayen and Karst, 2003; Niessen, 2003). The advantage of these methods is 
that as each compound is being eluted, it is captured by the mass spectrometer and 
provides an immediate molecular ion and/or major mass fragment, which allows for 
positive identification of the eluting “peak” (Gail et al, 2001).  
Other hyphenated techniques, such as liquid chromatography combined with nuclear 
magnetic resonance spectrometry (LC-NMR) and LC-NMR-MS, have been developed in 
recent years for on-line determination of natural products (Wolfender et al, 2003).  
The advent of the diode array detection (DAD) has brought compound identification to 
HPLC. Previously the sole domain of gas or liquid chromatography-mass spectrometry 
(GC-MS or LC-MS) peak identification and purity checking can now be done as part of 
HPLC analysis, and at a lower cost (Ludwig and Stephan, 1993). HPLC techniques often 
use absolute or relative retention times to identify chromatographic peaks. With the DAD, 
spectra can be acquired automatically as each peak elutes. Under well-defined conditions, 
UV spectra are useful data for the confirmation of peak identity (Ludwig and Stephan, 
1993). 
In recent years, capillary electrophoresis (CE) has expanded its scope and range of both 
instrumentation and application (Altria and Elder, 2004). Many CE methods have been 
developed for analysis of raw herbal materials and herbal products (Chen et al, 2004; 
Jiang et al, 2004; Feng et al, 2003). It was thought by many that CE would rapidly 
replace HPLC, but considerable previous investment in HPLC equipment purchases and 
training has created an analytical inertia that CE has found a difficult to change. CE often 
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offered only an alternative to HPLC, not an improvement, and therefore CE was not 
widely implemented (Altria and Elder, 2004).  
Besides quantifying marker compounds and chromatographic fingerprinting, quality 
control of herbal medicine also includes screening for western drug adulterants (Liu et al, 
2001, Koh and Woo, 2000) and determination of toxic heavy metals (Koh and Woo, 
2000). A combination of analytical methods is often required in the quality control of 
herbal medicine.  
1.4 Objectives  
The broad objective of this project is to develop analytical methods for the analysis of 
complex mixtures of botanical origins, in particular, for the quality control of some 
commonly used herbs in Singapore and around the region.  
Due to their complexity, quality control of herbal medicines is a challenge. The 
combination of several of analytical methods is often needed. In this study, we use 
bioactive components as markers for quality control of herbal medicines (e.g. Gastrodia 
elata) (Chapter 2). However, when the bioactive components are not available or not 
known, or they do not adequately reflect the total effects of the herbs, the whole 
chromatographic fingerprints of the extracts will be very useful for the differentiation of 
botanicals (Chapter 3). For Stephania tetrandra and Aristolochia fangchi herbs, a 
combination of HPLC-DAD and LC-MS/MS methods will be developed in this study 
(Chapter 4).  
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Thence, the specific objectives of this study are to 
1) develop HPLC methods for the chemical analysis, and identification of G. elata;  
2) develop HPLC methods for chromatographic fingerprinting analysis of some Chinese 
herbs which are commonly used in Singapore; and 
3) develop HPLC-DAD and LC-MS/MS methods for differentiation of some Chinese 
herbs. 
4) apply the developed methods to the analysis of selected herbal medicines and their 









Rhizoma Gastrodiae, Tianma （天麻）, is the dried tuber of Gastrodia elata Blume 
(Orchidaceae). The tuber is collected from winter to early spring, washed clean, steamed 
thoroughly and then dried at a low temperature (Tang and Eisenbrand, 1992). G. elata 
was listed in the ancient Shennong Bencao Jing (ca. 100 A.D.) and was later classified by 
Tao Hong as a superior herb, meaning that it could be taken for a long time to protect the 
health and prolong life (as well as treating illnesses). Now it is officially listed in the 
Chinese Pharmacopoeia (2000). The traditional use of G.  elata is to calm internal wind 
and dispel invading wind, and invigorate circulation in the meridians; thereby used as an 
anticonvulsant, analgesic, and sedative against vertigo, general paralysis, epilepsy, and 
tetanus. In this thesis, G.  elata will be used to refer to Rhizoma Gastrodiae, unless 
otherwise specified. 
2.1.1 Chemical constituents 
The tuber of G.  elata contains mainly phenolic compounds (Figure 2.1). Gastrodin (1) 
was isolated as the first active principle from G. elata (Zhou et al, 1979; Feng et al, 1979). 
4-hydroxybenzyl alcohol (2), which is the aglycone of gastrodin, and 4-
hydroxybenzaldehyde (3) were also isolated from the ethanol extracts (Zhou et al, 1979a). 
From the fresh tuber of G.  elata, another 5 phenolic compounds were isolated and 
identified as bis(4-hydroxyphenyl)methane (4), bis(4-hydroxybenzyl)ether (5), 3,4-
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dihydroxybenzaldehyde (6), 4-ethoxymethyl phenyl 4’-hydroxybenzyl ether (7), and 4-
hydroxybenzyl ethyl ether (8) (Zhou et al, 1980). Taguchi et al also reported 
gastrodioside (9), 4-hydroxybenzyl methyl ether (10), 4-(4’-hydroxybenzyl)benzyl 
methyl ether (11), and parishin (12) were isolated from the tube of G.  elata (Taguchi et 
al 1981). Another bis(4-hydroxybenzyl) derivative, 2,4-bis(4-hydroxybenzyl)phenol (13), 
was isolated from the methanolic extract (Naoki et al, 1995). S-(4-
hydroxybenzyl)glutathione (14) was isolated from water extracts (Andersson, et al, 1995). 
Parishin B (15) and parishin C (16) were isolated from 70% methanol extract (Lin et al 
1996). From the ethyl ether fraction prepared from the methanol extract, 4,4’-
dihydroxybenzyl sulfoxide (17) (Yun-Choi and Pyo, 1997) and cirsiumaldehyde (18) 
(Yun-Choi, et al, 1997) were isolated. Another two 4-hydroxybenzyl alcohol derivatives, 
3-O-(4’-hydroxybenzyl)-β-sitosterol (19) and 4-[4’-(4’’-
hydroxybenzyloxy)benzyloxy]benzyl methyl ether (20) were isolated from the methanol 
extract of fresh tuber (Yun-Choi, et al, 1998). Gastrol (21) was isolated from the MeOH 
extract of the rhizomes of G.  elata (Hayashi, et al, 2002).  
The tuber of G.  elata also contains other compounds (Tang and Eisenbrand, 1992), such 
as succinic acid (24), sucrose (25), β-sitosterol (26), daucosterol (27), citric acid, 2-
methyl ester (28), palmitic acid (29), citric acid (30), and citric acid 1,5-dimethyl ester  
(31). L-pyroglutamic acid (32) was isolated from the tuber of G.  elata collected in 
Guizhou (Hao, et al, 2000). α-acetylamino-phenylpropyl α-benzoylamino-
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Figure 2.1 (continued) 
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2.1.2 Biological activities 
2.1.2.1 Biological activities of G.  elata 
Koang et al (1958), first reported that G.  elata may be effective in the treatment of 
epilepsy. The aqueous extract of G.  elata, given intravenously, increased the threshold of 
electroshock-induced convulsions and inhibited the occurrence of seizures in 
experimentally epileptic guinea pigs. It also exhibited sedative effects in both the rat and 
mouse (Tang and Eisenbrand, 1992). G.  elata administered orally for 1 week could 
improve the scopolamine-induced learning and memory deficit in rats (Hsieh et al, 2000). 
G.  elata had anticonvulsive and free radical scavenging activity. It could significantly 
reduce kainic acid (KA)-induced lipid peroxide level in vitro, and delay the onset of wet 
dog shakes, paw tremor and facial myoclonia in KA-treated rats (Hsieh et al, 2001). Kim  
et al(2001), reported that the ether fraction of methanol extracts of G.  elata had 
anticonvulsive effect and putative neuroprotective effect against excitotoxicity induced 
by kainic acid. Huh et al (1998) also reported the methanol extracts of G.  elata could 
significantly inhibited the convulsion state as well as the level of lipid peroxidition in 
pentylenetetrazole (PTZ)-treated rat brain. Ha et al (2000), reported that the ethyl ether 
fraction of a methanol extract of G.  elata shortened the recovery time from and inhibited 
the severity of pentylenetetrazole (PTZ)-induced convulsions in rats. Pretreatment with 
this fraction prevented the decrease of brain GABA in rats given subconvulsive doses of 
PTZ. 
It was also reported that the extract of G.  elata had muscle relaxant effect in isolated 
guinea pig ileum (Lin, et al, 1997). G.  elata could also improve the response of condition 
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taste aversion, increase spontaneous locomotion, and enhance the ability of learning and 
memory in water-maze in mice after the rotation. The symptoms of motion sickness 
induced by rotation could be improved by G.  elata treatment (Wang, et al, 1999). The 
ethyl ether fraction of G.  elata could dramatically reduce amyloid beta-peptide induced 
neuronal cell death in vitro (Kim, et al, 2003). 
2.1.2.2 Biological activities of selected constituents of G.  elata 
The activities of gastrodin, 4-hydroxylbenzyl alcohol, L-pyroglutamic acid and others 
have also been reported. 
Gastrodin and 4-hydroxybenzyl alcohol 
Gastrodin and its genin, 4-hydroxybenzyl alcohol, showed sedative activity in mice, 
monkeys, rabbits, and human subjects. In addition, intravenously administered gastrodin 
and its genin had anticonvulsant activity in treatment of experimental epilepsy of the 
guinea pig (Tang and Eisenbrand, 1992). Both compounds were not toxic to mice when 
given orally or intravenously at doses below 5 g/kg. It was also reported that gastrodin 
and 4-hydroxybenzyl alcohol could facilitate memory consolidation and retrieveal (Hsieh, 
et al, 1997) and the facilitating effects of 4-hydroxybenzyl alcohol on learning and 
memory were better than those of gastrodin. Further studies showed that 4-
hydroxybenzyl alcohol might act through suppressing dopaminergic and serotonergic 
activities and thus improve learning.  
The physiological disposition of 3H-labeled gastrodin was investigated in rats. The 
decline in radioactivity from the gastrointestinal tract was rapid following oral 
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administration of gastrodin and only 1.1% of the dose was recovered from the 
gastrointestinal tract after 8 h. In rats given gastrodin intragastrically, the radioactivity 
level in blood was moderate at 5 min and reached its peak at 50 min after administration. 
Radioactivity was highest in kidneys, moderate in liver, lung, and uterus, and relatively 
lower in the brain, reaching a maximum at 2 h in the brain. The main metabolite of 
gastrodin detected by thin-layer chromatography was its genin, 4-hydroxybenzyl alcohol. 
The pharmacokinetics of gastrodin in rats reflected a circadian rhythm (Tang and 
Eisenbrand, 1992). 
4-hydroxybenzaldehyde 
4-hydroxybenzaldehyde showed an inhibitory effect on the lipid peroxidation. In the 
brains of pentylenetetrazole (PTZ) treated rats, the brain lipid peroxidation was 
significantly increased, while it recovered to the control level after treatment with 4-
hydroxybenzaldehyde. Furthermore, 4-hydroxybenzaldehyde showed an inhibitory effect 
on the GABA (γ-aminobutyric acid) transaminase (Ha et al, 2000). A recent study (Kim 
et al, 2003) showed that the ethyl ether fraction of G.  elata dramatically reduced amyloid 
β-peptide induced neuronal cell death in vitro. HPLC analysis demonstrated that this 
fraction contained mainly 4-hydroxybenzaldehyde. 
L-pyroglutamic acid 
It is reported that L-pyroglutamic acid has anticonvulsive effect (Dusticier et al, 1985). A 
competitive inhibition of the high affinity transport of glutamic acid by L-pyroglutamic 
acid was found in vitro with no effect on the uptake of γ-aminobutyric acid (GABA). 
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Other ingredients 
Vanillin (22) and vanillyl alcohol (23) have been reported to have anti-oxidant and free 
radical scavenging activities. Vanillin is a powerful scavenger of 1,1-dipheny-2-picry 
hydrazyl, superoxide and hydroxyl radicals and inhibits iron-dependent lipid peroxidation 
in rat brain homogenate, microsomes and mitochondria (Liu and Mori, 1993). Vanillyl 
alcohol has anticonvulsive and suppressive effects on seizures and lipid peroxidation 
induced by ferric chloride in rats. Vanillyl alcohol also has free radical scavenging 
activities, which may be responsible for its anticonvulsive properties (Hsieh et al, 2000). 
S-(4-hydroxybenzyl)glutathione was isolated as the major principle responsible for the 
inhibition of the in vitro binding of kainic acid to brain glutamate receptors by water 
extracts of G.  elata (Andersson et al, 1994). 4-hydroxy-3-methoxybenzaldehyde 
inhibited potently the activity of GABA transaminase (Ha JH et al, 2001). The anti-
thrombotic effect of citric acid 1,5 di-methyl ester was observed with prolonging the 
bleed time in thrombin-induced thrombosis model of mice (Pyo et al, 2000).  
2.1.3 Objectives  
The objectives of the study are to develop high performance liquid chromatography 
(HPLC) and solid phase extraction (SPE) methods using some bioactive constituents as 
markers for indication of the authenticity of G.  elata, and to determinate the major 
constituent, gastrodin, in G.  elata and in Chinese Proprietary Medicines (CPMs) 
containing G.  elata. It has been reported (Huang, 2000) that some faked samples of G.  
elata have been prepared from some other herbs or plants, such as Colocasia esculenta 
(L.) Schott (Yunai, 芋艿 ), Dahlia pinnata Cav. (Daliju, 大理菊 ), Mirabilis jalapa 
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L.(Zimoli, 紫茉莉), Cacalia tangutica (Franch) Hand.-Mazz. (Yuliexiejiacao, 羽裂蟹甲
草), Solanum tuberosum L. (Malingshu, 马铃薯), Ipomoea batatas (L.) Lam. (Ganshu, 甘
薯 ), Canna edulis Ker-Gawl. (Bajiaoyu, 芭蕉芋 ), Trichosanthes kirilowii Maxim. 
(Gualou, 栝楼), and Dobinca delavayi (Baill.) Engl. (Duobinqi, 多槟槭). Although the 
faked samples resemble like G. elata, their ingredients are quite different from those of G. 
elata. Therefore chemical profiling of G. elata would be useful for discerning it from its 
fakes and for quality control of this herb.  
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2.2 Preparation of gastrodin by HPLC 
2.2.1 Introduction 
The reference standards of herbal ingredients are often unavailable commercially. Even 
when available, the cost is often prohibitive, as it is difficult to obtain the pure standard in 
large quantity. In this study, gastrodin was obtained from Kunming Pharmacy Industry 
(Kunming). However, HPLC analysis showed that the compound is not of acceptable 
purity. The purpose of this section is to develop a semi-preparative HPLC method to 
purify this chemical and to confirm its structural characteristics based on UV, IR, ESI-
MS, 1H-NMR and 13C-NMR. The purity was checked by its m.p. and HPLC analysis. 
2.2.2 Experimental 
2.2.2.1 Materials and reagents 
Gastrodin (raw material, 63.9%) was provided by Kunming Pharmacy Industry 
(Kunming, China); Methanol and acetonitrile were of HPLC grade. Milli Q water 
(Millipore, France) was used. Methanol-d4 was from Sigma (St. Louis, MO, USA).  
2.2.2.2 HPLC conditions 
HPLC was performed using a Agilent 1100 HPLC series chromatograph equipped with 
Chem-Station Software version Rev.A.08.03, a degasser model G1322A, a QuatPump 
model G1311A, a column oven model G1316A, an autosampler model G1313A and a 
diode array detector model G1315B.  
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Gastrodin was prepared on a semi-preparative column, Inertsil Agilent ZORBAX SB-
C18 (9.4 × 250mm, 5µm), guarded by a ZORBAX cartridge column (9.4 mm ID × 15 
mm). A mixture of Milli Q water and methanol (90:10) was used as mobile phase. Flow 
rate was 2.5ml/min. Detection wavelength was 270nm. 
To evaluate the purity of the gastrodin prepared, an Inertsil ODS-3 column (4.6 mm × 
250mm, 5 µm) was used, operated at 35°C. The mobile phase was Milli Q water (A) and 
acetonitrile (B) with a gradient program as follows: 5%B to 30% B (15 min), 30% B to 
60% B (10 min), 60% B (5 min), post-run (10 min) at a flow rate of 1ml/min. The 
injection volume was 5 µl. Detection wavelength was 224nm. 
2.2.2.3 Melting point 
A Bausch and Lamb & hot-stage microscopy was used to determine melting points 
(uncorrected). 
2.2.2.4 Infrared spectrometry 
IR spectrum (KBr disc) was recorded on JASCO FT/IR-430 spectrometer (Japan).  
2.2.2.5 Ultraviolet spectrometry 
UV spectra were recorded on an Agilent G1315B diode array spectrometer (USA). Scan 




2.2.2.6 Mass spectrometry 
MS was measured on a Finnigan LCQ ion trap mass spectrometer (San Jose, CA). 
Electrospray interface was used.  
2.2.2.7 Nuclear magnetic resonance spectrometry 
NMR spectra were recorded by Bruker Advance DPX300 NMR Spectrometer (Germany) 
[300 MHz (1H) and 75 MHz (13C)] using methanol-d4 solution with tetramethylsilane 
(TMS) as an internal standard. 
2.2.3 Results and discussion 
Gastrodin (1) was prepared by the semi-preparative HPLC method as white powder. The 
melting point was measured as 156-157°. This agreed with the reported value (Taguchi et 
al, 1981). The purity was also checked by HPLC. Figure 2.2b shows the chromatogram of 
gastrodin after purification. The percentage area of gastrodin peak with respect to the 
total area was 63.9% before purification (Figure 2.2a) and increased to 98.2% after 
purification (Figure 2.2b).  
The ultraviolet spectrum exhibited absorption maxima λmax at 195, 220 and 270 nm 
(Figure 2.3). Such absorption was due to “OR” substituted benzene ring. Benzene 
absorbs at 184, 203 and 254 nm. When benzene ring is substituted by lone pair donating 
system, the wavelength of the absorption maximum will increase.  
Absorption bands in the IR spectrum (Figure 2.4) indicated that hydroxyl group (3600-
3200 cm-1) was present. Due to the hydrogen bond, O-H stretching frequency is shown as 
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the broad band in the range of 3600-3200 cm-1. The absorption band at 1240 can be due 
to O-H bending; while the band at 1076 cm-1 is due to C-O stretching (Nyquist, 2001).  
 The two bands at 1612 and1513 cm-1 indicated the presence of aromatic ring system. The 
band at 829 cm-1 is due to the out-of-plane C-H bending vibration. For para-disubstituted 
benzene ring system, the frequency of out-of-plane C-H bending is in the range of 860 to 
800 cm-1. 
The ammonium adduct molecular ion [M+NH4]+, m/z 304, can be detected by ESI-MS 
(Figure 2.5a). This ion was selected and further fragmented by collision induced 
dissociated (CID) to product ions. Figure 2.5b shows the characteristic product ions: 
[(M+NH4)-NH3]+ 287, [(M+NH4)-NH3-H2O]+ 269, and [(M+NH4)-NH3-glc]+ 107.  
The 1H NMR spectrum (Figure 2.6) showed signals due to four aromatic protons (δH 7.07, 
7.26, each 2H, d), the protons on the sugar unit (δH, 3.3-3.5, 4H, m, and 3.6-4.2, 2H, m), 
and the CH2 protons (δH, 4.53, 2H, s).  
The 13C NMR spectrum of 1 (Figure 2.7) showed signals due to an aromatic ring (δC, 
137.4, 130.0 [2×C], 118.5 [2×C], 159.3), a sugar unit (δC, 103.0, 78.9, 78.8, 75.7, 72.2, 
63.3) and (δC, 66.7). Comparison of 13C NMR of compound 1 with those of the literature 
(Table 2.1) revealed that compound 1 was gastrodin.  
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Figure 2.2 HPLC chromatograms of (a) gastrodin without purification, and (b) gastrodin 








Figure 2.3 UV spectrum of purified gastrodin  
 
 
Figure 2.4 IR spectrum of purified gastrodin  
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Figure 2.5 Mass spectra of gastrodin 
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Figure 2.6 1H-NMR spectrum of gastrodin 
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Table 2.1 Comparison of the 13C NMR spectral data of purified compound with those of 
gastrodin reported in literature (Taguchi et al, 1981). 
Chemical Shift (δ ppm) 
Carbon Number Measureda Reference data 
1 137.4 136.6 
2, 6 130.0 129.4 
3, 5 118.5 117.7 
4 159.3 158.4 
7 66.7 65.7 
1’ 103.0 102.4 
2’ 75.7 74.9 
3’ 78.9 78.0 
4’ 72.2 71.3 
5’ 78.8 77.9 
6’ 63.3 62.5 







A semi-preparative HPLC method has been successfully developed to purify gastrodin 
from the raw material purchased. The structure of the purified substance was confirmed 
by UV, IR, MS and NMR, and the spectroscopic data was consistent with the literature 
data for gastrodin. The melting point was consistent with reported values and the percent 
area of the purified peak to the total area was 98.2%. The purified gastrodin was therefore 
found suitable to be used as a standard in subsequent studies. 
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2.3 Detection and Determination of Bioactive Constituents in 
Gastrodia  elata by HPLC-DAD 
 
2.3.1 Introduction 
The quality control of herbs is very important to ensure the quality of the final products. 
Active constituents are often used as markers to indicate the authenticity of a herb or its 
product. Using one or several components as markers, several methods have been 
reported to analyze G. elata, such as high-performance liquid chromatography (HPLC) 
(Wei et al, 2001; Li et al, 2001), Gas chromatography (GC-MS) (Li et al, 2001a) micellar 
electrokinetic capillary chromatography (MEKC) (Ku et al, 1998 and 1998a) and 
capillary electrophoresis (CE) (Zhao et al, 1999; Wang et al, 2002). In today’s analytical 
laboratories, HPLC is commonly used, and diode array detection (DAD) is also used for 
routine analysis. The DAD can provide multiple-signal detection and peak identification. 
To date, no report on simultaneous determination of the four bioactive constituents as 
markers in G. elata can be found. In this study, a rapid and sensitive HPLC-DAD method 
has been developed, using the four active constituents as markers for analysis of G. elata. 
Quantitative analysis of gastrodin was performed at 224 nm in G.  elata and two CPMs 
containing 100% G.  elata. 
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2.3.2 Experimental 
2.3.2.1 Materials and reagents 
4-hydroxybenzyl alcohol, 4-hydroxybenzaldehyde and L-pyroglutamic acid of analytical 
grade were obtained from Sigma (St. Louis, United States). Gastrodin was provided by 
Kunming Pharmacy Industry (Kunming, China) and purified (Section 2.2) before use. 
Methanol and acetonitrile were of HPLC grade. Milli Q water (Millipore, France) was 
used.  
Three herbs of dried and sliced G.  elata were purchased from three local medical stores, 
and labeled as GE1, GE2 and GE3. Two different Chinese Proprietary Medicines (CPMs) 
in the form of capsules, containing 100% of G.  elata, were bought locally and labeled as 
CPM1 and CPM2. 
2.3.2.2 HPLC conditions 
The analysis was performed using an Agilent 1100 HPLC series. The column used was 
an Inertsil ODS-3 column (4.6 mm × 250mm, 5 µm), maintained at 35°C. The mobile 
phase was Milli Q water (A) and acetonitrile (B) with a gradient program as follows: 
5%B to 30% B (15 min), 30% B to 60% B (10 min), 60% B (5 min), post-run (10 min) at 
a flow rate of 1ml/min. The injection volume for all samples was 5 µl. Simultaneous 
monitoring was performed at 195 nm (for L-pyroglutamic acid), 270 nm (for gastrodin, 4-
hydrobenzyl alcohol, 4-hydrobenzaldehyde) and 224 nm (for gastrodin). Spectra were 
recorded from 190 to 400 nm. 
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2.3.2.3 Optimization of extraction 
Extractions were carried out either with 100% (v/v) or 70% (v/v) of methanol using a 
Soxhlet extractor or with triple extractions in an ultrasonic bath. 2 g of powdered samples 
for each group were accurately weighed. Soxhlet extractions were performed using 75 ml 
of solvent for 6 hours. In the ultrasonic bath extraction, samples were extracted for 20 
min with 30 ml of solvent. The extract was filtered, and fresh solvent was added. This 
procedure was performed in triplicate. The filtrates were combined and the solvents were 
evaporated off under reduced pressure. The residue was dissolved in 70% methanol, 
quantitatively transferred to 10 ml volumetric flasks and made up to volume. The solution 
was filtered through 0.45µm nylon membrane filter before HPLC analysis. 
2.3.2.4 Calibration curve 
Gastrodin standard was dissolved in methanol-water (30:70, v/v) yielding concentrations 
of 20, 50, 80, 140 and 200µg/ml. The solutions were filtered through a 0.45 µm 
membrane filter. Three different sets of solutions were prepared and analyzed each day 
and in three continuous days. Each calibration curve was fitted by linear regression. 
2.3.2.5 Validation 
The linearity was determined for the calibration curve obtained by LC analysis of 
gastrodin. The slop and other statistics of the calibration curve were determined by linear 
regression. 
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The intermediate precision was evaluated on the same day, while the inter-day precision 
was assessed for 3 consecutive days. The data were expressed as the relative standard 
deviation (RSD %). 
A standard solution of gastrodin was sequentially diluted and analyzed using HPLC. The 
limit of detection (LOD) was based on the signal-to-noise (S/N) ratio of 3, while the limit 
of quantification (LOQ) was base on the signal-to-noise (S/N) ratio of 10 (Snyder et al, 
1997).  
The accuracy was evaluated through recovery studies by adding known amounts of 
gastrodin at three different levels to the sample. The unspiked samples and each of the 
spiked samples were analyzed in triplicate and the recoveries were determined. 
2.3.3 Results and discussion 
2.3.3.1 Separation and detection of gastrodin, 4-hydroxybenzyl alcohol, 4-
hydroxybenzyladehyde, and L-pyroglutamic acid 
Figure 2.8 shows the UV spectra of the four compounds, GA, HA, HD and PGA. Three 
wavelengths have been selected for optimal sensitivity and selectivity: 195nm for PGA, 
270 nm for GA, HA and HD, and 224 nm for quantitative analysis of GA. The method 
included extraction of gastrodin from CPM samples, followed by a separation on HPLC 
using a reversed-phase column and detection by a DAD. Three signals were recorded 
simultaneously over the range from 190 to 400 nm. Gastrodin, 4-hydroxybenzyl alcohol 
and 4-hydroxybenzaldehyde can be detected at 270 nm (Figure 2.9), and L-pyroglutamic 
acid can be detected at 195 nm (Figure 2.10). To identify peaks in chromatograms, 
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retention times of chromatographic peaks were compared with those of the four reference 
standards (Table 2.2). 
Table 2.2. Comparison of the retention times (RT) of the standards with those in the 
samples 
RT [Mean±SD (min)] (n=3) 
Sample 
GA HA HD PGA 
Standards 7.016±0.018 10.128±0.012 16.698±0.024 3.773±0.006 
GE1 7.015±0.025 10.126±0.026 16.698±0.040 3.773±0.006 
GE2 7.018±0.022 10.129±0.017 16.699±0.043 3.774±0.006 
GE3 7.010±0.039 10.120±0.034 16.698±0.034 3.772±0.007 
CPM1 7.018±0.020 10.130±0.015 16.689±0.045 3.774±0.006 
CPM2 7.016±0.025 10.128±0.011 16.694±0.047 3.772±0.006 
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Figure 2.8 UV spectra of  (a) gastrodin, (b) 4-hydroxybenzyl alcohol, (c) 4-
hydroxybenzaldehyde and (d) L-pyroglutamic acid 
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Figure 2.9 Chromatograms of (a) gastrodin (GA), (b) 4-hydroxybenzyl alcohol (HA), (c) 
4-hydroxybenzaldehyde (HD) and (d) extract of G.  elata at 270 nm 
 


































Figure 2.10 Chromatograms of (a) L-pyroglutamic acid (PGA) and (b) extract of G.  elata 






















2.3.3.2 Quantitative analysis of gastrodin  
Quantitative HPLC determination of gastrodin was performed at its maximum 
absorbance wavelength, 224 nm (Figure 2.11). Extractions with 70% methanol by 
Soxhlet extraction was found to afford the highest yield of gastrodin in the samples 
(Figure 2.12). Calibration curves for gastrodin were linear in the concentration range 20-
200 µg/ml. The LOD and LOQ were 0.70µg/ml and 2.57µg/ml respectively.  
The precision of the method was evaluated. The intra-day and inter-day RSD values were 
less than 1.31% (Table 2.3). 
 Table 2.3 Intra-day and inter-day analytical precisions using five concentrations (20.0-
200 µg/ml) of gastrodin 
RSD (%) (n=3) Concentration 
(µg/ml) Intra-day Inter-day 
20.0 0.22 0.61 
50.0 0.06 0.78 
80.0 0.47 1.31 
140.0 0.92 0.86 







Figure 2.11 Chromatograms of (a) gastrodin and (b) extract of G.  elata at 224 nm 






















































The accuracy was investigated with recovery test. The recovery of the method was 
determined with the standard addition method for gastrodin in G.  elata with results 
ranging from 91.4% to 101.9% (Table 2.4).  











4.91 4.91 100.0 99.3±1.0 1.01 
4.89 4.88 99.8   
4.85 4.85 98.2   
10.04 10.23 101.9 98.9±2.6 2.63 
9.99 9.67 96.8   
10.10 9.91 98.1   
15.09 15.06 99.8 95.5±4.2 4.40 
15.52 14.18 91.4   
15.53 14.81 95.4   
Table 2.5 The contents of gastrodin in the samples and daily recommended dose 
Sample Concentration mean±SD 
(mg/g) (n=3) 
Daily recommended dose (g) Calculated daily dose of 
gastrodin (mg) 
 Herb GE1 4.07±0.01 3 to 9* 12.21 to 36.63 
Herb GE2 3.48±0.01 3 to 9* 10.44 to 31.32 
Herb GE3 4.49±0.02 3 to 9* 15.87 to 40.41 
CPM1 2.97±0.02 2 capsules three times a day 7.07 
CPM2 6.17±0.12 2 capsules three times a day 18.70 
* Daily recommended dose from reference (Pharmacopoeia of the People’s Republic of China, 2000) 
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In this study, the contents of gastrodin in the three herbal samples were from 3.48 to 4.49 
mg/g (Table 2.5). The gastrodin contents in G.  elata could vary, depending on the 
collection seasons and culturing areas. A previous report showed that the average content 
of gastrodin was 3.1 mg/g in September samples, 2.3 mg/g in December samples and 9.3 
mg/g in July samples. It was also reported (Zhang and Liu, 1983) that gastrodin content 
in G.  elata ranged from 1.6 mg/g to 11.8 mg/g, as determined in the samples from 
various areas.  
CPM2 was found to contain twice as much gastrodin as CPM1 (Table 2.5), although both 
claimed to contain 100% G.  elata powder. Nowadays, G.  elata has been widely cultured. 
However, the content of gastrodin in cultured G.  elata is normally less than those in the 
G.  elata grown wild (Zhu, 1998). CPM2 was claimed to be prepared from G.  elata 
grown wild.  
The Chinese Pharmacopoeia (2000) states that the recommended daily dose of G.  elata 
is 3 to 9g. The concentrations of gastrodin found in the 3 herbal samples range from 3.48 
to 4.49 mg/g. This corresponds to a daily dose of gastrodin ranging from 12.2 to 15.9 mg 
per day (Table 2.5). The two CPMs are capsules containing 100% of powdered G.  elata 
as labeled. The frequency of administration is 2 capsules, three times a day for each of 
the CPM. From the concentration of gastrodin found in the CPM samples and the weight 
of contents per capsule, the daily dose of gastrodin can be calculated (Table 2.5). 
Consuming CPM1 delivers 7 mg of gastrodin per day while consuming CPM2 delivers 
18.7 mg of gastrodin. The calculated dose of gastrodin from CPM2 falls within the 
calculated daily dose of gastrodin according to the dosage of G.  elata given in the 
Chinese Pharmacopoeia.  
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2.3.4 Conclusion 
Using four bioactive components as markers, a rapid and sensitive HPLC-DAD method 
has been developed for analysis of G.  elata and for the determination of gastrodin, its 
major bioactive constituent. This validated method was applied on three locally bought G.  
elata and two CPMs containing 100% G.  elata. The CPM claimed to be prepared from G. 
elata grown wild has more than twice the content of gastrodin than the one from cultured 




2.4 Determination of Gastrodin in Chinese Proprietary 
Medicines Containing Gastrodia  elata by Solid Phase 
Extraction and HPLC 
 
2.4.1 Introduction 
G.  elata has been traditionally used in oriental countries for a few thousand of years. 
And there are several traditional formulas with this herb that come to us today. Most of 
the ancient formulas with G.  elata are designed to treat convulsions, such as occurs with 
tetanus or epilepsy, stroke, and headaches. Based on these formulas, some Chinese 
Proprietary Medicines (CPMs) were developed in the form of tablets, pills and capsules.  
In these formulas, G.  elata is the principal ingredient, and plays the major role in treating 
diseases. Gastrodin is the major active constituents of G.  elata. Hence, for quality control 
of these CPMs, gastrodin is selected as a marker. 
Due to the complexity of the matrix in the CPMs, cleanup of the extracts prior to 
chromatography is very important for both precise measurement and preservation of 
chromatographic system. Solid Phase Extraction (SPE) has been widely used to cleanup 
biological samples (Poole, 2003; Simpson, 2000; Hennion, 1999). However, there are 
relatively few reports about its use on herbal products. 
Many methods have been developed for analysis of G.  elata (Zhao et al, 1999; Wei et al, 
2001; Li et al, 2001 and 2001a). However, little has been reported for its products. The 
purpose of this study is to develop an SPE HPLC method for determination of gastrodin 
in the CPMs containing G.  elata.  
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2.4.2 Experimental 
2.4.2.1 Materials and reagents 
Gastrodin was provided by Kunming Pharmacy Industry (Kunming, China) and purified 
(Section 2.2) before use. The acetonitrile and methanol were of HPLC grade. Milli Q 
water (Millipore, France) was used.  
Four different CPMs were bought in local medical halls. Their ingredients and the 
percentage of each herb used as claimed in the label are shown in Table 2.6. 
2.4.2.2 HPLC conditions 
The analysis was performed using an Agilent 1100 HPLC series. The column used was 
an Inerstil ODS-3 column (4.6 mm × 250 mm, 5 µm), maintained at 35°C. The mobile 
phase was Milli Q water-acetonitrile-methanol (90:5:5) at a flow rate of 1ml/min. The 
injection volume for all samples was 5 µl. The detection wavelength was set at 224 nm. 
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Table 2.6 CPM ingredients and their weight percentage  
CPM Name Ingredients of CPM Percentage 
Wild G.  elata  Rhizoma Gastrodiae（Tianma天麻） 20% 
Tablet (CPM3) Radix Angelicae Sinensis (Danggui 当归) 20% 
野生天麻片 Cortex Eucommiae (Duzhong 杜仲) 14% 
 Radix Rehmanniae (Dihuang 地黄) 32% 
 Radix Scrophulariae (Xuanshen 玄参) 12% 
 Radix Angelicae Pubescentis (Duhuo 独活) 10% 
Tian-Ma-Wan Pill  Rhizoma Gastrodiae（Tianma天麻） 8.2% 
(CPM4) Radix Rehmanniae (Dihuang 地黄) 21.9% 
天麻丸 Rhizoma et Radix Notopterygii （Qianghuo 羌活） 13.7% 
 Radix Angelicae Sinensis (Danggui 当归) 13.7% 
 Radix Achyranthis Bidentatae （Huainiuxi 怀牛膝） 8.2% 
 Rhizoma Dioscoreae Hypoglaucae （Bixie 荜薤） 8.2% 
 Cortex Eucommiae (Duzhong 杜仲) 9.6% 
 Radix Scrophulariae (Xuanshen 玄参)  8.2% 
 Radix Angelicae Pubescentis (Duhuo 独活) 6.9% 
 Aconiti Tuber Laterale （Fuzi 附子） 1.4% 
Capsules for the  Rhizoma Gastrodiae（Tianma天麻） 30% 
Stubborn Headache  Radix Polygoni Multiflori （Heshouwu 何首乌） 15% 
(CPM5) Fructus Ligustri Lucidi（Nüzhenzi 女贞子） 20% 
顽固头痛胶囊 Fructus Schisandrae （Wuweizi 五味子） 15% 
 Rhizoma Ligustici Chuanxiong （Chuanxiong 川芎） 10% 
 Radix Angelicae Dahuricae （Baizhi 白芷） 10% 
Qiangli-Tian-Ma-Du-  Rhizoma Gastrodiae（Tianma天麻） 9.6% 
 Zhong Capsule  Cortex Eucommiae (Duzhong 杜仲) 10.2% 
(CPM6) Radix Aconiti Kusnezoffii Preparata （Zhicaowu 制草乌） 1.2% 
强力天麻杜仲胶囊 Radxi Aconiti Lateralis Preparata （Zhifuzi 制附子） 1.2% 
 Radix Angelicae Pubescentis (Duhuo 独活) 6.0% 
 Rhizoma Ligusticum（Haoben 蒿本） 7.1% 
 Radix Scrophulariae (Xuanshen 玄参) 7.1% 
 Radix Angelicae Sinensis (Danggui 当归) 12.8% 
 Radix Rehmanniae (Dihuang 地黄) 19.4% 
 Radix Cyathulae （Chuanniuxi 川牛膝） 7.1% 
 Herba Visci （Hujisheng 槲寄生） 7.1% 
 Rhizoma et Radix Notopterygii（Qianghuo 羌活） 12.0% 
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2.4.2.3 Solid phase extraction method 
Waters Oasis® HLB SPE cartridges (1cc/30mg) were used. The cartridge was conditioned 
with 1 ml methanol, and equilibrated with 2 ml Milli Q water. 1 ml sample was loaded, 
and eluted with 1 ml 10% methanol. The eluate was collected in a vial for HPLC analysis. 
The SPE scheme is illustrated in Figure 2.13. 
 





1 ml methanol 
Equilibrate 
2 ml Milli Q Water 
Load 
1 ml CPM extract 
Elute 




2.4.3 Results and discussion 
2.4.3.1 Solid phase extraction 
The chemical constituents in the CPMs are very complex, and thus it is difficult to 
analyze them. The products used in this study consist of at least six raw herbs (Table 2.6). 
All possess very complex chemical compositions and without passing through SPE 
cartridges, quantitatively analysis of gastrodin in these products can be very difficult.  
Oasis HLB SPE cartridges were employed for the sample cleanup. The Oasis HLB 
sorbent is a macroporous copolymer made from a balanced ratio of two monomers, the 
lipophilic divinylbenzene and the hydrophilic N-vinylpyrrolidone (Waters, 2004). They 
can be dried during extraction. For normal C18 cartridges, the cartridges must always be 
kept wet during the cleanup except the finial elution step. Unlike traditional C18 bonded 
silica sorbent, the Oasis HLB copolymer reversed-phase adsorption mechanism is 
uncomplicated by the often irreproducible population of surface silanols or metal 
impurities. This kind of sorbent is usually suitable for extraction of a wide range of 
compounds, especially polar compounds (Waters, 2004). Under the developed SPE 
protocol, the recoveries of GA standard solution applied onto the SPE cartridges ranged 
from 92.0 to 100.4% (Table 2.7). 
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18.66 18.73 100.4 97.2±3.8 3.91 
 18.32 98.2   
 17.36 93.0   
36.38 33.99 93.6 93.2±1.2 1.24 
 33.48 92.0   
 34.30 94.2   
55.68 51.90 93.3 93.3±0.4 0.39 
 51.78 93.0   
 52.17 93.7   
 
 
Table2.9 Contents of gastrodin in four Chinese Proprietary Medicines 







2.4.3.2 Choice of separation conditions  
When the separation was carried out with mobile phase flow rat at 1.0 ml/min and 35 °C 
column temperature, using a mobile phase of Milli Q water-methanol-acetonitrile (90:5:5, 
v/v/v), good resolution between gastrodin and its adjacent peaks was achieved (Figure 
2.14).  
2.4.3.3 Linearity and sensitivity 
Good linearity was obtained in the concentration range of 10-100 µg/ml with the 
following regression equation. 
A=9.6041C+0.2625 
(r2 = 0.99999; n=5, SD for the slope = 0.0861; SD for the intercept = 0.8951) 
where A is the peak area (mAU*S), and C is the concentration of gastrodin solution 
(µg/ml ). 
The limit of detection (signal-to-noise ratio of 3) was 0.8µg/ml. And the limit of 
quantification (signal-to-noise ratio of 10) was 3.0µg/ml. 
2.4.3.4 Recovery 
The recovery of the method was determined with the standard addition method for 
gastrodin in the four CPMs with results ranging from 82.8 to 91.2% (Table 2.8). 
Compared with the recovery of GA standard solution applied onto SPE cartridges (Table 
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2.7), the recovery of gastrodin from the CPM was about 7% lower. This could be due to 
the complex matrix in the CPMs.  
2.4.3.5 Application  
The contents of GA in the four CPM samples were determined. Figure 2.14 shows the 
typical chromatograms of those samples. Table 4 shows the measurement results. The 
contents of GA in the four CPM samples ranged from 0.4-1.32 mg/g. 
Table2.8 Recoveries of gastrodin added into CPM samples prior to extraction 
Samples Recovery 
(%) 
 Mean±SD  






























Figure 2.14 Typical chromatograms of extracts of four Chinese herbal products: (a) Wild 
Gastrodia elata Tablet (CPM3), (b) Tian-Ma-Wan Pill (CPM4), (c) Capsules for the 
Stubborn Headache (CPM5) and (d) QiangLi-Tian-Ma-Du-Zhong Capsule (CPM6) 
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A simple and rapid SPE HPLC method for determination of gastrodin in four CPMs was 
successfully developed. This method has been validated for linearity, precision, LOD and 
LOQ. The developed method could be useful and suitable for quality control of the four 




Chapter 3 HPLC Profiling of Herbal Medicines 
3.1 Introduction 
Due to their complex constituents, quality control of herbal medicines has been a 
challenge. Bioactive constituents are often used as markers for quality assurance of herbal 
medicines (Thompson and Morris, 2001). However, in a large array of herbal medicines, 
the active substances are not known specifically. Chromatographic fingerprint analysis has 
been introduced and accepted by World Health Organization (1991) as a strategy for the 
assessment of herbal medicines. Chromatographic fingerprint is also required by the Drug 
Administration Bureau of China (2000) to standardize injections made from traditional 
Chinese medicines and their raw materials. Chromatographic fingerprinting is 
recommended by U.S. Food and Drug Administration (2002) be used to standardize the 
extracts or preparations of herbs.  
3.1.1 Chromatographic fingerprint analysis of herbal medicines 
A HPLC chromatogram can be thought of as a chemical fingerprint where the pattern 
emerges from the relative intensities of the sequence of peaks passing by the detector. In 
many cases, the interpretation of chromatographic output is to hold an overlay of two 
chromatograms up to a window to see if the two chromatograms have “significant” 
difference. Chemometrics can afford us the ability to substitute an objective mechanism 
for the human pattern recognition step (Brereton, 1992). A peak table, retention time as 
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index and area as measurement variable, can be generated from the output of a 
chromatogram. Then, multivariate data analysis can be carried out.  
The use of fingerprinting in herbs tends to focus on identifying and assessing the source 
and quality of the medicinal plants. HPLC fingerprint analysis of some Chinese herbs 
(Zhao et al, 2004; Zhang et al, 2003; Chen et al, 2003; Zeng et al, 2002 and 2003; Cheng 
et al, 2003 and 2003a; Li et al, 2004 and 2004a; Hao et al, 2002;) and their products (Cao 
et al, 2004; Wang et al, 2002 and 2002a; Gong et al, 2003 and 2004;) have been reported. 
For example, Chen et al (2003) used HPLC fingerprinting for identifying the habitat of 
Ligusticum chuanxiong. Cao et al (2004) developed a HPLC fingerprint method for 
quality control of QingKaiLing injection.  
3.1.2 Common problem associated with naming of Chinese herbs 
Common names for some Chinese herbs often overlap, causing confusion as to the proper 
identity. For example, Fangji and Guangfangji are traditionally called “Fangji” in China. 
However, they are from two different medicinal plants: Stephania tetrandra and 
Aristolochia fangchi (Tang et al, 1992). Their chemical components are also different 
(Tang et al, 1992). A more extensive discussion of the two herbs can be found in Section 
4.1. Due to their different pharmacological actions, using the wrong herb can lead to 
undesirable consequences. In Belgium, at least 70 people required renal transplant or 
dialysis due to interstitial fibrosis of the kidney after taking the wrong herb from the 
Aristolochiaceae family (Vanherwegnem et al, 1993). Aristolochia fangchi contains the 
nephrotoxic aristolochic acids (Tang et al, 1992). Instead of Stephania tetrandra, the toxic 
A. fangchi was used. Hence, WHO recommends the use of Latin binomial names, and not 
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the common names. Chromatographic fingerprinting is a useful technique for 
distinguishing between herbs.  
3.1.3 Cluster Analysis 
Cluster analysis is a popular technique whose basic objective is to discover sample 
groupings within data (Beebe, 1998). Clustering methods are divided into three categories, 
hierarchical, object-functional, and graph theoretical. Hierarchical methods are the most 
popular. 
For cluster analysis, each sample is treated as a point in an n-dimensional measurement 
space. The coordinate axes of this space are defined by the measurements used to 
characterize the samples. Cluster analysis assesses the similarity between samples by 
measuring the distances between the points in the measurement space. Samples that are 
similar will lie close to one another, whereas dissimilar samples are distant from each 
other. The choice of the distance metric to express similarity between samples in a data set 
depends on the type of measurement variables used. 
Three types of variables – categorical, ordinal, and continuous – are typically used to 
characterize chemical samples. 
Measurement variables are usually continuous. For continuous variables, the Euclidean 
distance is the best choice for the distance metric, because interpoint distances between 
the samples can be computed directly (Figure 3.1) (Massart and Kaufman, 1983). 
However, there is a problem with using the Euclidean distance, which is the so-called 
scaling effect. It arises from inadvertent weighting of the variables in the analysis that can 
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occur due to differences in magnitude among the measurement variables. The influence of 
variable scaling on the Euclidean distance can be mitigated by autoscaling the data, which 
involves standardizing the measurement variables, so that each variable has a mean of 









−=                                                        (3.1) 
where xi,orig is the original measurement variable i, mi,orig is the mean of the original 
measurement variable I, and si,orig is the standard deviation of the original measurement 
variable i. Clearly, autoscaling ensures that each measurement variable has an equal 
weight in the analysis. For cluster analysis, it is best to autoscale the data, because 










Figure 3.1 Euclidean distances between two data points in a two-dimensional 







Clustering methods attempt to find clusters of patterns (i.e. data points) in the 
measurement space, hence the term cluster analysis. Although several clustering 
algorithms exist, e.g. K-means, K-median, Patric-Jarvis, FCV (fuzzy clustering varieties), 
hierarchical clustering is by far the most widely used clustering method. The starting point 
for a hierarchical clustering experiment is the similarity matrix which is formed by first 
computing the distances between all pairs of points in the data set. Each distance is then 




ds ikik −=                                                                  (3.2) 
where sik (which varies from 0 to 1) is the similarity between samples i and k, dik is the 
Euclidean distance between samples i and k, and dmax is the distance between the two most 
dissimilar samples (i.e. the largest distance) in the data set. The similarity values are 
organized in the form of a table or matrix. The similarity matrix is then scanned for the 
largest value, which corresponds to the most similar point pair. The two samples 
constituting the point pair are combined to form a new point, which is located midway 
between the two original points. The rows and columns corresponding to the old data 
points are then removed from the matrix. The similarity matrix for the data set is then 
recomputed. In other words, the matrix is updated to include information about the 
similarity between the new point and every other point in the data set. The new nearest 
point pair is identified, and combined to form a single point. This process is repeated until 
all points have been linked (Brereton, 1992). 
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Figure 3.2 The distance between a data cluster and a point using single linkage, complete 
linkage and average linkage. 
 
There are a variety of ways to compute the distances between data points and clusters in 
hierarchical clustering (Figure 3.2). The single-linkage method assesses similarity 
between a point and a cluster of points by measuring the distance to the closest point in 
the cluster. The complete linkage method assesses similarity by measuring the distance to 
the farthest point in the cluster. Average linkage assesses the similarity by computing the 
distances between all point pairs where a member of each pair belongs to the cluster. The 
average of these distances is used to compute the similarity between the data point and the 
cluster (Lavine, 1992). Each linkage has its advantages and disadvantages. The average 
method results in a better measure of the distance between clusters when the clusters are 
well separated. This is because it measures the distance between the centers of the clusters 
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hand, the average method is sensitive to outliers because these unusual points adversely 
influence the calculation of the average of a cluster. With well-separated classes, all 
methods give similar results (Beebe, 1998). In this study, the average linkage method is 
employed.  
To illustrate the method, consider the hypothetical data set and similarity matrix in Table 
3.1 and 3.2. Table 3.1 presents the data for five objectives, which have two variables (v1 
and v2). Table 3.2 gives their similarity matrix.  
Table 3.1 Observations of five objects 
 v1 v2
Object    1 1 1
Object    2 1 2
Object    3 5 4
Object    4 7 5
Object    5 7 7
Table 3.2 Similarity matrix (of observations in Table 3.1) 
  1 2 3 4 5
Object  1  0.88 0.41 0.15 0.00
Object  2 0.88  0.47 0.21 0.08
Object  3 0.41 0.47 0.74 0.58
Object  4 0.15 0.21 0.74  0.76
Object  5 0.00 0.08 0.58 0.76   
The similarity matrix is then scanned for the largest value. This is a value of 0.88 between 
object 1 and 2. Hence, object 1 and 2 should be combined to form a new point (A). Table 
3.3 shows the updated similarity matrix, implying highest similarity between two objects. 
The average linkage method was chosen for assessing the similarity between a data point 
and a point cluster.  
Table 3.3 Updated similarity matrix (from Table 3.2) 
  A 3 4 5
Cluster  A  0.45 0.19 0.05
Object  3 0.45 0.74 0.58
Object  4 0.19 0.74 0.76
Object  5 0.05 0.58 0.76  
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The updated similarity matrix is then scanned for the largest value (0.76); the nearest pair 
(object 4 and 5) is combined to form a single point (B). The similarity matrix is then 
updated (Table 3.4) to include information about the similarity between the new point (B) 
and every other point in the data set.  This process is repeated, and the two clusters A and 
B (Table 3.5) are finally merged together at a similarity of 0.20.  
Table 3.4 Updated similarity matrix (from Table 3.3) 
  A 3 B
Cluster  A  0.45 0.12
Object  3 0.45 0.67
Cluster  B 0.12 0.67   
Table 3.5 Updated similarity matrix (from Table 3.4) 
  A B
Cluster  A  0.20
Cluster  B 0.20   
 
 
Figure 3.2 Average-linkage dendrogram of the hypothetical data set (Table 3.1).   
The results of a hierarchical clustering study are usually displayed as a dendrogram 















dendrogram shows the merging of samples into clusters at various stages of the analysis 
and the similarities at which the clusters merge, with the clustering displayed 
hierarchically. Interpretation of the results is intuitive, which is the major reason for the 
popularity of these methods. 
3.1.4 Objective 
The objective of this work is to develop a HPLC method for fingerprinting analysis of 
some commonly used Chinese herbs in Singapore. Some marker compounds are also 
identified in the herbal samples by HPLC-DAD. 
3.2 Experimental 
3.2.1 Materials and reagents 
Thirty-four Chinese herbs (Table 3.6) were purchased.  Twenty-seven of them were from 
three retailers – Eu Yan Sang (EYS), Sinchong Meheco (SINC) and Wong Yiu Nam 
(WYN) in Chinatown, Singapore; and another 7 were purchased from China, including the 
reference herb (Guangfangji) purchased from the National Institute for the Control of 
Pharmaceutical and Biological Products (NICPBP) (Beijing, China). 
Aristolochic acid I (AAI), fangchinoline, tetrandrine, baicalin, indigotin and catapol were 
obtained from the National Institute for the Control of Pharmaceutical and Biological 
Products (NICPBP) (Beijing, China). 4-hydroxybenzyl alcohol, 4-hydroxybenzaldehyde 
and L-pyroglutamic acid of analytical grade were obtained from Sigma (St. Louis, USA).  
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Table 3.6 List of Traditional Chinese Herbal Medicines and their sources 
No Chinese Name Responding Latin Binomial Name Source 
1 Fangji （防己） Radix Stephaniae Tetrandrae Eu Yan Sang (Singapore)  
2 Fangji（防己） Radix Stephaniae Tetrandrae Wong Yiu Nam Medical Hall  
3 Fangji（防己） Radix Stephaniae Tetrandrae Sinchong Meheco  
4 Guangfangji（广防己） Radix Aristolochiae Fangchi Guangzhou, China 
5 Guangfangji（广防己） Radix Aristolochiae Fangchi Beijing, China 
6 Hanzhongfangji 
（汉中防己） 
Radix Aristolochiae Heterophyllae Shanxi, China 
7 Fangji（防己） Radix Stephaniae Tetrandrae Shenyang, China 
8 Fangji（防己） Radix Stephaniae Tetrandrae TongRenTang, Beijing, China 
9 Fangji（防己） Radix Stephaniae Tetrandrae LeRenTang, Shijiazhuang, China 
10 Fangji（防己） Radix Stephaniae Tetrandrae Shibao Co, Shijiazhuang, China 
11 Tianma（天麻） Rhizoma Gastrodiae Eu Yan Sang (Singapore)  
12 Tianma（天麻） Rhizoma Gastrodiae Wong Yiu Nam Medical  
13 Tianma（天麻） Rhizoma Gastrodiae Sinchong Meheco  
14 Huangqin（黄芩） Radix Scutellariae Eu Yan Sang (Singapore)  
15 Huangqin（黄芩） Radix Scutellariae Wong Yiu Nam Medical Hall  
16 Huangqin（黄芩） Radix Scutellariae Sinchong Meheco 
17 Madouling（马兜玲） Fructus Aristolochiae Eu Yan Sang (Singapore)  
18 Madouling（马兜玲） Fructus Aristolochiae Wong Yiu Nam Medical Hall  
19 Madouling（马兜玲） Fructus Aristolochiae Sinchong Meheco  
20 Duzhong（杜仲） Cortex Eucommiae Eu Yan Sang (Singapore)  
21 Duzhong（杜仲） Cortex Eucommiae Wong Yiu Nam Medical Hall  
22 Duzhong（杜仲） Cortex Eucommiae Sinchong Meheco  
23 Banlangen（板蓝根） Radix Isatidis Eu Yan Sang (Singapore)  
24 Banlangen（板蓝根） Radix Isatidis Wong Yiu Nam Medical Hall  
25 Banlangen（板蓝根） Radix Isatidis Sinchong Meheco  
26 Banxia（半夏） Rhizoma Pinelliae Eu Yan Sang (Singapore)  
27 Banxia（半夏） Rhizoma Pinelliae Wong Yiu Nam Medical Hall  
28 Banxia（半夏） Rhizoma Pinelliae Sinchong Meheco  
29 Shengdi（生地） Radix Rehmanniae Eu Yan Sang (Singapore)  
30 Shengdi（生地） Radix Rehmanniae Wong Yiu Nam Medical Hall  
31 Shengdi（生地） Radix Rehmanniae Sinchong Meheco  
32 Shudi（熟地） Radix Rehmanniae Preparate Eu Yan Sang (Singapore)  
33 Shudi（熟地） Radix Rehmanniae Preparate Wong Yiu Nam Medical Hall  
34 Shudi（熟地） Radix Rehmanniae Preparate Sinchong Meheco  
 65
Gastrodin was provided by Kunming Pharmacy Industry (Kunming, China) and purified 
(Section 2.2) before use. 
The solvents, acetonitrile and methanol, were of HPLC grade. All the chemical standards 
were from National Institute for Control of Pharmaceutical and Biological Products 
(Beijing, China).  Milli Q water (>18 mΩ) (Milli Pore, France) were used. Other reagents 
were of analytical grade. 
3.2.2 HPLC conditions 
The analysis was performed using an Agilent 1100 HPLC series chromatography. The 
column used was an Inertsil ODS-3 column (4.6 mm × 250mm, 5 µm), maintained at 
35°C. The mobile phase was 0.01% H3PO4 (v/v) in Milli Q water (pH 3.0) (A) and 
acetonitrile (B) with a gradient program as follows: 5%B to 100% B (55 min), 100% B to 
100% B (5 min), post-run (10 min) at a flow rate of 1ml/min. The injection volume for all 
samples was 5 µl. Detection wavelength was 210 nm. The UV spectra from 190 to 400 nm 
were recorded during the chromatographic run.  
3.2.3 Sample preparation 
2 g of powdered herbs were accurately weighed.  10 ml of 70% (v/v) of methanol were 
added, and then extracted under ultrasonic water bath for 20 min. The process was 
repeated 3 times for each herb. After filtration, the combined methanol extracts were 
evaporated to dryness by a rotary evaporator. The residue was dissolved in 10 ml of 70% 
methanol and filtered by 0.45 µm membrane before analysis.  
 66
For detection and identification of marker compounds, 4-hydroxybenzyl alcohol (HA) was 
spiked in as an internal standard in the reference standards and samples. All the chemical 
standards were also dissolved in 70% methanol and filtered by 0.45 µm membrane before 
inject into HPLC system.   
3.2.4 HPLC fingerprint analysis  
3.2.4.1 Chromatographic fingerprinting 
A chromatographic fingerprint was mathematically represented by a vector of peak areas 
in this study. Chromatographic peak areas for each chromatographic were obtained by 
computer integration and entered into a spreadsheet. The peaks were assigned their 
retention times manually. A peak table was developed by examining integration reports 
and adding features to the table which did not match the retention times of previous 
observed features. A preliminary data vector was produced for each chromatogram by 
matching the retention times of HPLC peaks with the retention times of the features in the 
table. A feature would be assigned a value corresponding to the area of the HPLC peak in 
the chromatogram. Unmatched peaks were zeroed. Finally, 81 peaks were selected in the 
table, although not all peaks were present in all chromatograms. Hence, for cluster 
analysis, each liquid chromatogram was initially represented as a 81-dimensional data 
vector, x = (x1, x2, x3, …, xj, …, x81), where xj is the jth peak. The data vectors were 




3.2.4.2 Data Analysis 
All data analyses were performed on a Pentium-based IBM-compatible personal computer. 
The MINITAB Release 13.20 for windows software (Minitab Inc., USA) was used to 
perform the hierarchical cluster analysis.  
 3.2.5 Detection and identification of marker compounds  
3.2.5.1 UV library of chemical standards 
LC-UV Library G218x (Rev.A.01.00) was used for developing the UV spectra database of 
chemical reference standards.  
3.2.5.2 RT and RRT of chemical standards 
Relative retention time (RRT) is determined by the ratio of retention time of chemical 
standard (RT) to the retention time of internal standard (RTIS): 
ISRT
RTRRT =
                            (3.3) 
All chemical reference standards were analyzed on three different days. The data of RT 
and RTIS were recorded and RRT were calculated based on the above formula.  
3.2.5.3 Peak identification 
Of these 34 TCMs, 12 TCMs were selected based on the availability of reference 
standards and screened for their marker compounds by HPLC-DAD. With a DAD, the 
identity of the compounds in the samples was carried out by comparing the RT, RRT and 
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UV spectra with those of the reference standard. Before a library search, a peak would be 
checked for purity. If not, spectral contribution arising from the impurity might overlay 
with the main compound and give an incorrect library search result. Figure 3.4 c shows a 
typical chromatogram of Madouling. The peak eluting at 35.6 min was first checked by 
comparing the normalized spectra at the peak upslope, apex and downslope. Next, the 
peak upslope spectrum was subtracted from the apex spectrum to eliminate small spectral 
irregularities arising from the sample matrix, the so-called chemical noise. Then the 
corrected spectrum was compared with those in a library. 
When comparing standard library with unknown spectra, the computer calculated a match 
factor. This factor indicates how closely the unknown spectrum matches the library 
spectrum. At the extremes, a match factor 0 indicates no match and 1000 indicates 
identical spectra. Generally, values above 990 indicate that the spectra are similar. Values 
between 900 and 990 indicate there is some similarity but the result should be interpreted 
with caution. All values below 900 indicate, in effect, that the spectra are different (Huber 
and George, 1993).  
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     (a)        (b) 
          
       (c)  
 
Figure 3.4 (a) Peak purity check by overlaying normalized spectra acquired in the upslope, 
apex, and downslope of the peak; (b) Overlaid UV spectra of peak at 35.6 min in 
Madouling (continuous line) and that of AAI standard (broken line); and (c) typical 
chromatogram of an extract of Madouling 
  











nm200 225 250 275 300 325 350 375
Purity factor: 997.374










*DAD1, 35.573 (Apex) of MaDouLing
*AAI standard 
Match factor: 983.527 
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3.3 Results and discussion 
3.3.1 Choice of HPLC conditions 
A gradient HPLC method was developed to elute the complex constituents of the herbs. 
210 nm was selected as detection wavelength, because most herbal constituents have good 
absorption at low detection wavelength. However, if the detection wavelength is lower 
than 210 nm, it may cause a baseline shift when gradient program is performed. To detect 
acidic and basic ingredients, 0.01% H3PO4 (v/v) was used. At 210 nm, the UV absorbance 
of 0.01% H3PO4 solution is very small, which does not lead to baseline shift (Snyder, 
1997).   
3.3.2 Chromatographic fingerprint analysis 
3.3.2.1 HPLC profiling  
Thirty-four herbs (Table 3.6) purchased from China and three local herbal halls, EYS, 
WYN and SINC, were profiled by the HPLC method. A chromatographic fingerprint is a 
set of peaks of a chromatogram that represents the characteristics of a sample. Figure 3.5 
shows a typical chromatogram of an extract of Huangqin. In this study, the reverse phase 
column was used. The polar components elute more quickly than the less polar ones. The 





Figure 3.5 Typical HPLC chromatogram of an extract of Huangqin  










3.3.2.2 Comparison of the similarity of chromatographic fingerprints 
Euclidean distance was used as the similarity measure in this work. As described in 
Section 3.2.4.1, each chromatographic fingerprint was regarded as an 81-dimentional 
vector. To compare the similarity of two chromatographic fingerprints, the Euclidean 
distance of two vectors were calculated. The smaller the Euclidean distance is, the larger 
the similarity.  The value of Euclidean distance is a relative indicator. It should be 
compared under the same system. Table 3.7 lists the Euclidean distance matrix of the 
thirty four Chinese herbs studies.  
3.3.2.3 Hierarchical Cluster Analysis 
Hierarchical cluster analysis (HCA) is the process of subdivision of a group of samples 
into clusters that exhibit a high degree of both intra-cluster similarity and inter-cluster 
dissimilarity.  HCA was applied to the entire normalized area matrix to explore the 
structure of the area data. The Euclidean distance was used to measure the similarities 
between clusters. The average method was applied to link the clusters.  
Figure 3.6 depicts the HCA results presented in the form of a dendrogram. Ten 
distinguished clusters were classified with similarity higher than 70%. The Madouling 
samples (17, 18 and 19), Huangqin samples (14, 15 and 16), Tianma samples (11, 12 and 
13), and Banxia samples (26, 27 and 28) were clustered respectively as group B, C, D and 
I. 
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Table 3.7 Euclidean distance matrix of thirty-four Chinese herbs 
Euclidean Distance Case 
1 2 3 4 5 6 7 8 9 10 11 12 
1  0.056 0.063 0.028 0.102 0.125 0.136 0.330 0.330 0.128 0.227 0.216 
2 0.056  0.053 0.043 0.098 0.149 0.161 0.342 0.341 0.147 0.248 0.238 
3 0.063 0.053  0.043 0.078 0.123 0.138 0.330 0.330 0.127 0.230 0.219 
4 0.028 0.043 0.043  0.091 0.123 0.133 0.330 0.330 0.127 0.229 0.218 
5 0.102 0.098 0.078 0.091  0.121 0.138 0.327 0.327 0.116 0.224 0.213 
6 0.125 0.149 0.123 0.123 0.121  0.057 0.294 0.295 0.092 0.178 0.164 
7 0.136 0.161 0.138 0.133 0.138 0.057  0.301 0.303 0.121 0.191 0.179 
8 0.330 0.342 0.330 0.330 0.327 0.294 0.301  0.013 0.304 0.350 0.344 
9 0.330 0.341 0.330 0.330 0.327 0.295 0.303 0.013  0.304 0.349 0.343 
10 0.128 0.147 0.127 0.127 0.116 0.092 0.121 0.304 0.304  0.206 0.195 
11 0.227 0.248 0.230 0.229 0.224 0.178 0.191 0.350 0.349 0.206  0.037 
12 0.216 0.238 0.219 0.218 0.213 0.164 0.179 0.344 0.343 0.195 0.037  
13 0.227 0.247 0.230 0.230 0.225 0.179 0.192 0.350 0.349 0.207 0.031 0.055 
14 0.221 0.237 0.215 0.221 0.214 0.188 0.209 0.343 0.342 0.190 0.248 0.239 
15 0.229 0.245 0.221 0.230 0.222 0.200 0.219 0.349 0.349 0.200 0.257 0.249 
16 0.246 0.261 0.241 0.248 0.242 0.221 0.238 0.361 0.361 0.221 0.273 0.266 
17 0.300 0.311 0.300 0.301 0.295 0.272 0.284 0.403 0.402 0.282 0.324 0.316 
18 0.225 0.237 0.225 0.224 0.214 0.197 0.211 0.357 0.356 0.205 0.262 0.253 
19 0.229 0.244 0.230 0.229 0.222 0.196 0.211 0.358 0.357 0.207 0.257 0.247 
20 0.196 0.221 0.197 0.201 0.199 0.147 0.161 0.333 0.334 0.175 0.234 0.217 
21 0.190 0.212 0.189 0.193 0.186 0.141 0.165 0.315 0.314 0.161 0.213 0.204 
22 0.211 0.230 0.209 0.213 0.207 0.170 0.193 0.326 0.326 0.184 0.234 0.227 
23 0.196 0.212 0.195 0.196 0.189 0.154 0.176 0.314 0.313 0.163 0.208 0.205 
24 0.351 0.361 0.351 0.351 0.348 0.331 0.341 0.435 0.435 0.331 0.369 0.364 
25 0.218 0.236 0.221 0.220 0.214 0.183 0.202 0.288 0.287 0.191 0.251 0.242 
26 0.183 0.203 0.178 0.180 0.180 0.117 0.119 0.321 0.323 0.152 0.219 0.208 
27 0.162 0.186 0.165 0.164 0.165 0.110 0.133 0.317 0.318 0.133 0.188 0.174 
28 0.172 0.195 0.176 0.175 0.173 0.132 0.155 0.320 0.321 0.137 0.208 0.197 
29 0.187 0.219 0.201 0.194 0.207 0.140 0.127 0.335 0.338 0.184 0.242 0.230 
30 0.184 0.216 0.199 0.192 0.203 0.141 0.129 0.337 0.340 0.181 0.239 0.224 
31 0.197 0.227 0.210 0.202 0.218 0.153 0.127 0.345 0.349 0.198 0.250 0.237 
32 0.183 0.211 0.191 0.186 0.197 0.127 0.104 0.331 0.334 0.176 0.235 0.222 
33 0.141 0.178 0.161 0.151 0.163 0.109 0.125 0.316 0.316 0.133 0.209 0.195 




Table 3.7 (Continued) 
Euclidean Distance 
Case 
13 14 15 16 17 18 19 20 21 22 23 
1 0.227 0.221 0.229 0.246 0.300 0.225 0.229 0.196 0.190 0.211 0.196 
2 0.247 0.237 0.245 0.261 0.311 0.237 0.244 0.221 0.212 0.230 0.212 
3 0.230 0.215 0.221 0.241 0.300 0.225 0.230 0.197 0.189 0.209 0.195 
4 0.230 0.221 0.230 0.248 0.301 0.224 0.229 0.201 0.193 0.213 0.196 
5 0.225 0.214 0.222 0.242 0.295 0.214 0.222 0.199 0.186 0.207 0.189 
6 0.179 0.188 0.200 0.221 0.272 0.197 0.196 0.147 0.141 0.170 0.154 
7 0.192 0.209 0.219 0.238 0.284 0.211 0.211 0.161 0.165 0.193 0.176 
8 0.350 0.343 0.349 0.361 0.403 0.357 0.358 0.333 0.315 0.326 0.314 
9 0.349 0.342 0.349 0.361 0.402 0.356 0.357 0.334 0.314 0.326 0.313 
10 0.207 0.190 0.200 0.221 0.282 0.205 0.207 0.175 0.161 0.184 0.163 
11 0.031 0.248 0.257 0.273 0.324 0.262 0.257 0.234 0.213 0.234 0.208 
12 0.055 0.239 0.249 0.266 0.316 0.253 0.247 0.217 0.204 0.227 0.205 
13  0.248 0.257 0.274 0.324 0.265 0.259 0.226 0.209 0.232 0.204 
14 0.248  0.049 0.056 0.318 0.258 0.255 0.230 0.213 0.230 0.216 
15 0.257 0.049  0.052 0.326 0.267 0.265 0.238 0.222 0.239 0.228 
16 0.274 0.056 0.052  0.338 0.283 0.281 0.257 0.242 0.257 0.246 
17 0.324 0.318 0.326 0.338  0.095 0.099 0.309 0.302 0.316 0.299 
18 0.265 0.258 0.267 0.283 0.095  0.052 0.257 0.242 0.256 0.236 
19 0.259 0.255 0.265 0.281 0.099 0.052  0.253 0.237 0.252 0.234 
20 0.226 0.230 0.238 0.257 0.309 0.257 0.253  0.148 0.199 0.212 
21 0.209 0.213 0.222 0.242 0.302 0.242 0.237 0.148  0.064 0.188 
22 0.232 0.230 0.239 0.257 0.316 0.256 0.252 0.199 0.064  0.207 
23 0.204 0.216 0.228 0.246 0.299 0.234 0.234 0.212 0.188 0.207  
24 0.369 0.363 0.370 0.381 0.421 0.377 0.376 0.359 0.349 0.359 0.212 
25 0.251 0.240 0.249 0.266 0.313 0.255 0.250 0.237 0.216 0.231 0.110 
26 0.220 0.205 0.216 0.234 0.303 0.240 0.235 0.180 0.287 0.204 0.175 
27 0.191 0.200 0.211 0.230 0.293 0.224 0.216 0.175 0.166 0.187 0.164 
28 0.208 0.140 0.147 0.162 0.296 0.229 0.225 0.187 0.173 0.194 0.171 
29 0.239 0.241 0.249 0.265 0.254 0.207 0.206 0.173 0.197 0.228 0.218 
30 0.234 0.241 0.249 0.265 0.316 0.262 0.259 0.136 0.190 0.228 0.217 
31 0.247 0.254 0.262 0.277 0.330 0.275 0.274 0.177 0.211 0.241 0.229 
32 0.233 0.238 0.247 0.263 0.276 0.224 0.222 0.166 0.195 0.225 0.213 
33 0.206 0.203 0.214 0.232 0.277 0.212 0.208 0.133 0.159 0.193 0.180 
34 0.219 0.224 0.233 0.251 0.298 0.240 0.239 0.103 0.167 0.209 0.195 
Continued 
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Table 3.7 (Continued) 
Euclidean Distance 
Case 
24 25 26 27 28 29 30 31 32 33 34 
1 0.351 0.218 0.183 0.162 0.172 0.187 0.184 0.197 0.183 0.141 0.173 
2 0.361 0.236 0.203 0.186 0.195 0.219 0.216 0.227 0.211 0.178 0.202 
3 0.351 0.221 0.178 0.165 0.176 0.201 0.199 0.210 0.191 0.161 0.181 
4 0.351 0.220 0.180 0.164 0.175 0.194 0.192 0.202 0.186 0.151 0.178 
5 0.348 0.214 0.180 0.165 0.173 0.207 0.203 0.218 0.197 0.163 0.182 
6 0.331 0.183 0.117 0.110 0.132 0.140 0.141 0.153 0.127 0.109 0.117 
7 0.341 0.202 0.119 0.133 0.155 0.127 0.129 0.127 0.104 0.125 0.116 
8 0.435 0.288 0.321 0.317 0.320 0.335 0.337 0.345 0.331 0.316 0.326 
9 0.435 0.287 0.323 0.318 0.321 0.338 0.340 0.349 0.334 0.316 0.328 
10 0.331 0.191 0.152 0.133 0.137 0.184 0.181 0.198 0.176 0.133 0.159 
11 0.369 0.251 0.219 0.188 0.208 0.242 0.239 0.250 0.235 0.209 0.224 
12 0.364 0.242 0.208 0.174 0.197 0.230 0.224 0.237 0.222 0.195 0.208 
13 0.369 0.251 0.220 0.191 0.208 0.239 0.234 0.247 0.233 0.206 0.219 
14 0.363 0.240 0.205 0.200 0.140 0.241 0.241 0.254 0.238 0.203 0.224 
15 0.370 0.249 0.216 0.211 0.147 0.249 0.249 0.262 0.247 0.214 0.233 
16 0.381 0.266 0.234 0.230 0.162 0.265 0.265 0.277 0.263 0.232 0.251 
17 0.421 0.313 0.303 0.293 0.296 0.254 0.316 0.330 0.276 0.277 0.298 
18 0.377 0.255 0.240 0.224 0.229 0.207 0.262 0.275 0.224 0.212 0.240 
19 0.376 0.250 0.235 0.216 0.225 0.206 0.259 0.274 0.222 0.208 0.239 
20 0.359 0.237 0.180 0.175 0.187 0.173 0.136 0.177 0.166 0.133 0.103 
21 0.349 0.216 0.287 0.166 0.173 0.197 0.190 0.211 0.195 0.159 0.167 
22 0.359 0.231 0.204 0.187 0.194 0.228 0.228 0.241 0.225 0.193 0.209 
23 0.212 0.110 0.175 0.164 0.171 0.218 0.217 0.229 0.213 0.180 0.195 
24  0.203 0.344 0.339 0.342 0.365 0.362 0.367 0.361 0.343 0.350 
25 0.203  0.215 0.198 0.199 0.230 0.230 0.245 0.228 0.194 0.218 
26 0.344 0.215  0.102 0.137 0.150 0.147 0.146 0.129 0.147 0.132 
27 0.339 0.198 0.102  0.105 0.169 0.162 0.180 0.160 0.125 0.144 
28 0.342 0.199 0.137 0.105  0.185 0.179 0.198 0.181 0.138 0.163 
29 0.365 0.230 0.150 0.169 0.185  0.087 0.099 0.048 0.119 0.100 
30 0.362 0.230 0.147 0.162 0.179 0.087  0.065 0.075 0.113 0.064 
31 0.367 0.245 0.146 0.180 0.198 0.099 0.065  0.069 0.148 0.102 
32 0.361 0.228 0.129 0.160 0.181 0.048 0.075 0.069  0.127 0.093 
33 0.343 0.194 0.147 0.125 0.138 0.119 0.113 0.148 0.127  0.101 
34 0.350 0.218 0.132 0.144 0.163 0.100 0.064 0.102 0.093 0.101  
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Figure 3.6 Dendrogram of thirty-four Chinese herbs using average linkage method 
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All three Fangji samples bought locally (1, 2 and 3) were clustered with Guangfangji 
(Guangzhou) (4) and reference Guangfangji (Beijing) (5) as a group (G); while two Fangji 
samples from China (8 and 9) were clustered as group A. Figure 3.7 shows the overlaid 
chromatograms of these five samples. Their chromatographic fingerprints have good 
similarity. Thus three Fangji samples from local herbal halls could be Guangfangji.  
The Fangji sample from Shenyang (7) was clustered with Hanzhongfangji (6) and the 
Fangji sample from Shijiazhuang (10) as group H. This indicates that the Fangji samples 
bought in Shenyang and Shijiazhuang (Sample 7 and 10) are not Stephania tetrandra.  
As mentioned in Section 3.1.2 and more extensively in section 4.1,  many reported cases 
of renal failure were due to the wrong use of Guangfangji (Aristolochia fangchi) instead of 
the intended Fangji (Stephania tetrandrae) (Vanherwegnem et al., 1993; Cosyns et al., 
2003; Zhou et al., 2004). Further studies on the local Fangji samples are needed to 
establish their identities. 
The Banlangen sample from WYN (24) was not clustered with another two Banlangen 
samples (23 and 25). Figure 3.8 shows the overlaid chromatograms of these three samples. 
Further work on Banlangen is currently in progress.  
The Duzhong sample from EYS (20) was also not clustered with the other two Duzhong 
samples (21 and 22). Figure 3.9 shows the overlaid chromatograms of these three 




Figure 3.7 Overlaid chromatograms of Fangji from (a) EYS, (b) WYN, (c) SINC and 
Guangfangji from (d) Guangzhou and (e) Beijing  








Figure 3.8 Overlaid chromatograms of extracts of Banlangen from (a) EYS, (b) WYN and 
(c) SINC 







Figure 3.9 Chromatograms of extracts of Duzhong from (a) EYS, (b) WYN and (c) SINC 





The three Shengdi samples (sample 29-31) and three Shudi samples (sample 32-34) were 
clustered into group J and were not differentiated under this system (Figure 3.10). Shudi is 
the steam-processed Shengdi (Pharmacopoeia of the People’s Republic of China, 2000). 
Processing of Chinese herbs is very important for their effect and quality. The processing 
of herb can reduce toxicity or side effect or/and potentiate effects (Zhu, 1998). The 
chromatograms of these extracts showed largely unresolved peaks in the retention time 
between 2 to 10 minutes under the current chromatographic conditions. This may have 
contributed to the similarity of the chromatograms as determined by the hierarchical 
cluster analysis. Optimised separation of the components may allow greater differentiation 
between Shengdihuang and Shudihuang samples.  
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Figure 3.10 Overlaid chromatograms of extracts of Shudihuang from (a) EYS, (b) WYN, 
and (c) SINC, and extracts of Shengdihuang from (d) EYS, (e) WYN and (f) SINC 
 








3.3.3 Detection of marker compounds by HPLC-DAD 
3.3.3.1 RT and RRT  
The RT and RRT of 8 reference standards have been recorded and calculated (Table 3.8). 
4-hydroxybenzyl alcohol (HA) was spiked in as an internal standard. The variation of the 
RT and RRT were also investigated. RSD of RT ranged between 0.347% and 1.546%, 
while RSD of RRT was from 0.031% to 0.971%. RSDs of RTs of the reference standards 
were generally smaller than that of RRT. This indicates that the variation of relative 
retention time is smaller than that of absolute retention time.  
Table 3.8 Retention time (RT) and relative retention time (RRT) of standards 
RT(min) (n=3) RRT (n=3) Chemical standards 
mean  SD RSD mean SD RSD 
Aristolochic acid I 35.653 0.135 0.377 3.521 0.032 0.908 
Fangchinoline 14.255 0.223 1.566 1.397 0.014 0.971 
Tetrandrine 15.326 0.203 1.325 1.502 0.013 0.861 
Gastrodin 7.033 0.026 0.373 0.698 0.001 0.031 
4-Hydroxybenzaldehyde 16.147 0.056 0.347 1.601 0.001 0.067 
Baicalin 21.229 0.204 0.961 2.088 0.018 0.870 
Indigotin 18.521 0.072 0.389 1.838 0.008 0.464 
Catapol 5.260 0.027 0.509 0.524 0.002 0.315 
 
 84
3.3.3.2 Peak identification 
A combination of retention time and spectral match was used for the identification of the 
peaks of interest. Table 3.9 shows the RTs and RRTs and the UV match factors of the 
peaks of interest. The percentage difference of the RTs of the suspected marker compound 
peaks compared with those of the reference standards were less than 6%. The percentage 
difference of the RRT of the peaks of interest and those of the reference standards were 
less than 3%.  
Most of the marker compounds were found to be present in the samples (Table 3.9). In the 
samples of Fangji from local medical halls, fangchinoline and tetrandrine were not found, 
but AA I was instead found present. However the content of AA I in these three samples 
was much lower than that in the reference Guangfangji.   
The purity factors of the peaks were generally above 950, except for the AAI peak in 
Fangji samples from EYS and WYN. The UV match factors were generally high (≥900) 
except for the AAI peaks in the local Fangji samples. 
From the results, it could be concluded that fangchinoline and tetrandrine were detected in 
the Fangji samples from Tongrentang and Lerentang, while gastrodin was detected in all 
three local samples of Tianma and indigotin was detected in all three local samples of 
Banlangen. Other results have to be treated with caution, in particular, the presence of 
AAI in local Fangji samples. Further work to confirm the presence of AAI in the local 
Fangji samples will be presented in Chapter 4.  
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Table 3.9 RT and RRT of target compound peak in the samples and their differences 
compared with the standard values 




















Madouling_EYS AAI 35.571 3.535 -0.230 0.403 997.374 983.527 
Madouling_SINC AAI 35.552 3.534 -0.283 0.379 979.349 899.119 
Madolling_WYN AAI 35.549 3.537 -0.292 0.450 994.462 960.153 
Fangji_EYS AAI 35.486 3.530 -0.468 0.262 821.232 695.430 
Fangji_SINC AAI 35.561 3.538 -0.258 0.484 964.640 743.039 
Fangji_WYN AAI 35.585 3.539 -0.191 0.522 825.039 773.034 
Guangfangji_Ref AAI 35.708 3.496 0.154 -0.710 999.629 999.849 
Fangji_TRT fangchinoline 14.325 1.385 0.491 -0.869 999.822 999.709 
Fangji_LRT fangchinoline 14.375 1.383 0.842 -1.011 999.918 999.898 
Fangji_TRT tetrandrine 15.365 1.485 0.254 -1.105 930.491 999.737 
Fangji_LRT tetrandrine 15.406 1.482 0.522 -1.328 992.955 999.866 
Tianma_EYS GA 7.001 0.698 -0.005 -0.069 999.969 999.904 
Tianma_SINC GA 7.004 0.697 -0.004 -0.076 999.953 999.979 
Tianma_WYN GA 7.003 0.698 -0.004 -0.040 999.954 999.917 
Tianma_EYS HD 16.189 1.613 0.260 0.745 989.868 896.541 
Tianma_SINC HD 16.188 1.612 0.254 0.689 997.286 881.236 
Tianma_WYN HD 16.182 1.612 0.217 0.702 999.140 899.594 
Huangqin_EYS baicalin 21.303 2.084 0.349 -0.170 998.602 983.306 
Huangqin_SINC baicalin 21.369 2.078 0.659 -0.465 997.870 974.514 
Huangqin_WYN baicalin 21.409 2.071 0.848 -0.809 998.966 993.455 
Banlangen_EYS indigotin 18.472 1.843 -0.265 0.260 999.809 999.978 
Banlangen_SINC indigotin 18.466 1.841 -0.297 0.157 999.798 999.831 
Banlangen_WYN indigotin 18.465 1.840 -0.302 0.132 999.799 999.880 
Shengdi_EYS catapol 5.114 0.511 -2.776 -2.453 972.379 901.756 
Shengdi_SINC catapol 5.218 0.514 -0.798 -1.843 969.964 891.891 
Shengdi_WYN catapol 5.267 0.514 0.133 -1.879 952.968 938.491 
Shudi_EYS catapol 5.431 0.519 3.251 -1.036 960.460 842.947 
Shudi_SINC catapol 5.523 0.525 5.000 0.172 985.526 957.366 
Shudi_WYN catapol 5.564 0.530 5.779 1.146 983.352 881.254 






The present study demonstrated a simple HPLC method for fingerprinting analysis of 
some Chinese Herbal Medicines. Extracts of thirty-four herbal samples, constituting 11 
different types of herbs were analyzed by HPLC. The chromatograms were further subject 
to hierarchical cluster analysis. Results showed that three samples bought as “Fangji” 
(Stephania tetrandra) in Singapore may be actually Guangfangji (Aristolochia fangji) 
instead. Further studies (Chapter 4) need to be carried out to confirm this finding. The 
HPLC fingerprint method developed can be potentially used for the differentiation of 
some Chinese Herbal Medicines. 
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Chapter 4. Differentiation and Authentication of 
Stephania tetrandra and Aristolochia fangchi by 
HPLC-DAD and LC-MS/MS 
4.1 Introduction 
Radix Stephaniae Tetrandrae, Fangji 防己（also called Fenfangji 粉防己, or Hanfangji 
汉防己）, is the dry roots of Stephania tetrandra S. Moore (Menispermaceae). Radix 
Aristolochiae Fangchi, or also known as Guangfangji 广防己 , is the dry root of 
Aristolochia fangchi Y.C. Wu ex L. D. Chou et S. M. Hwang. Both herbs have been 
traditionally used as diuretic in China (Tang et al, 1992). However, their chemical 
constituents are quite different. The main chemical constituents in the roots of S. 
tetrandra are the alkaloids, tetrandrine and fangchinoline; while aristolochic acid I 
(AAI) is the major bioactive constituent of the root of A. fangchi (Figure 4.1) (Tang et 
al, 1992).  
Tetrandrine and fangchinoline exhibit the characteristics of Ca2+ channel blocker 
(King, et al, 1988, Liu et al, 1991, 1992; Weinsberg et al, 1994; Kim et al, 1997). 
They have inhibitory activities on human platelet aggregation (Kim et al, 1999, 
1999a), anti-inflammatory effects (Shen et al, 2001), hypotensive effects (Kim et al, 
1997) and cardiopretective effects (Yu et al, 2001), neuroprotective effects (Kim et al, 
2001; Koh et al, 2003). Tsutsumi et al (2003) reported that fangchinoline has anti-
hyperglycemic effect; while tetrandrine has no such effect. Tetrandrine was also 
reported to be potentially useful as a chemotherapeutic/chemopreventive agent in 
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Figure 4.1 Chemical structures of tetrandrine, fangchinoline and aristolochic acid I. 
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Aristolochic acids (AA), a mixture of structurally related nitrophenanthrene 
carboxylic acids, with AAI being the major component, were reported to be 
nephrotoxin and carcinogen. In February 1993, Vanherweghem reported that many 
young women patients, after taking a slimming regimen that included Chinese herbs, 
experienced renal failure (Vanherwegnem et al, 1993). The nephropathy that was 
characterized by a rapid deterioration in renal function and biopsy displayed extensive 
interstitial fibrosis without glomerular lesions, as well as atrophy and loss of tubules. 
The nephritic symptoms are initially called Chinese Herbs Nephropathy (CHN) 
(Cosyns, et al, 1994). Suspicion that the disease was due to the introduction of 
Chinese herbs in the slimming regimen was reinforced by identification in the 
slimming pills of the nephrotoxic and carcinogenic aristolochic acid extracted from 
species of Aristolochia (Vanherwegnem et al, 1994). This hypothesis was 
substantiated by the identification of pre-mutagenic AA-DNA adducts in the kidney 
and ureteric tissues of CHN patients. Finally, induction of clinical features typical of 
CHN in rodents given AA alone removed any doubt on the causal role of this 
phytotoxin in CHN, now better called aristolochic acid nephropathy (AAN) (Cosyns 
et al, 2003). Nortier et al (2000) also found cancer in 18 of 39 Belgians who had been 
diagnosed with end-stage kidney failure caused by Aristolochia fangchi. Outside the 
Belgian epidemic, at least 65 cases of CHN have been reported worldwide and most 
of these cases could be classified as AAN patients (Cosyns et al, 2003). Several 
countries, including Canada, Australia, Germany and UK, banned the use of herbs 
containing AA (Kessler, 2000). 
The roots of Stephaniae tetrandra and Aristolochia fangchi are similar in appearance 
and their products in the markets are usually sold in the form of slices. The physical 
differentiation between the two herbs is difficult. The quantification of fangchinoline 
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and tetrandrine in Stephaniae tetrandra (Yang et al, 1998 and Li et al, 2004) and 
aristolochic acids in Aristolochia fangchi (Ong et al, 2000; Hashimoto et al, 1999; 
Ioset et al, 2003; and Hanna, 2004) have been extensively studied. However, there are 
no comparative studies on analysis of both herbs. The purpose of this work is to 
develop HPLC-DAD and LC/MS methods for the differentiation of Stephania 
tetrandra and Aristolochia fangchi. 
4.2 Experimental 
4.2.1 Chemicals and materials 
Aristolochic acid I, fangchinoline and tetrandrine were obtained from the National 
Institute for the Control of Pharmaceutical and Biological Products (NICPBP) 
(Beijing, China). Methanol and acetonitrile were of HPLC grade. Milli Q water 
(Millipore, France) was used. Stephania tetrandrae (Fangji) was bought from 
Tongrentang (Beijing, China), and the reference Aristolochia fangchi (Guangfangji) 
was from NICPBP (Beijing, China) 
Ten dried and sliced Stephania tetrandrae (Fangji) (as claimed) were purchased from 
local medical halls (Table 4.1).  
4.2.2 Sample preparation 
2 grams of powdered herbs were accurately weighed and were ultrasonicated with 20 
ml methanol for 20 min. The process was repeated 3 times for each herb. After 
filtration, the combined methanol extracts were evaporated to dryness by a rotary 
evaporator. The residue was dissolved in 10 ml methanol and filtered by 0.45 µm 
membrane before analysis. 
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Table 4.1 Local sources of herbs bought as Fangji (Stephania tetrandra) 
No Source Address Price 
(SIN$) 
1 Eu Yan Sang (Singapore) PTE LTD 269, South Bridge Road 1.00 
2 Wong Yiu Nam Medical Hall PTE LTD 51 Temple Street 1.60 
3 Sinchong Meheco LTD #03-19 Pearl’s Center  
100 EU Tong Seng Street  
2.20 
4 Thye Shan Medical Hall PTE Ltd 201 New Bridge Road 2.00 
5 Teck Soon Medical Hall PTE Ltd 231 South Bridge Road 1.60 
6 TCM Chinese Medicines PTE Ltd #02-32 Pearl’s Center 
100 EU Tong Seng Street 
1.00 
7 Teck Soon Medical Hall No. 22 Smith Street 1.00 
8 Heng Say Tong Medical Hall PTE Ltd 101, Upper Cross Street  
#01-29 People’s Park 
Center 
1.50 
9 Teck Yin Soon Chinese Medical Hall  71 Temple Street  1.20 
10 Ban Tai Loy Medical Hall 276 South Bridge Road 1.60 
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4.2.3 HPLC-DAD conditions 
The analysis was performed using an Agilent 1100 HPLC series. The column used 
was an Inertsil ODS-3 column (4.6 mm × 250mm, 5 µm), maintained at 35°C. The 
mobile phase was 0.01% H3PO4 (v/v) in Milli Q water (pH 3.0) (A) and acetonitrile 
(B) with a gradient program as follows: 5%B to 100% B (55 min), 100% B to 100% B 
(5 min), post-run (10 min) at a flow rate of 1ml/min. The injection volume for all 
samples was 5 µl. Detection wavelength was 210 nm. UV scan was set from 200 to 
400 nm. 
4.2.4 LC/MS conditions 
A Spectra Series HPLC (Finnigan, San Jose, USA ) equipped with an autosampler 
was used. Separation were performed using on a Luna 5u C18(2) (2.0 × 150 mm, 5 µ), 
at a flow rate of 0.3 ml/min. The mobile phase was 0.1% acetic acid (v/v) in Milli Q 
water (A) and methanol (B) with a gradient program: 5%-100% (B) in 20 minutes. 
Mass spectrometric analysis was performed on a Finnigan LCQ ion trap mass 
spectrometer (San Jose, USA) equipped with an air-pressured chemical ionization 
(APCI) interface. Positive ionization mode was applied. The following APCI 
parameters was optimized for detection of AAI, tetrandrine and fangchinoline: 
vaporizer temperature (ramped from 150°C to 500°C in steps of 50°C), capillary 
temperature (increased from 125°C to 275°C in steps of 25°C) and tube lens offset 
(increased from -50V to 50V in steps of 10V). The HPLC fluid was nebulized using 
N2 as both the sheath gas at a flow rate of 60 au (arbitrary units), and auxiliary gas at a 
flow rate of 5 au. Collision induced dissociation (CID) experiments, MS-MS, were 
conducted using helium as the collision gas, and the relative collision energy was set 
at 35-60%. 
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4.3 Results and discussion 
4.3.1 HPLC-DAD analysis 
4.3.1.1 HPLC profiling of roots of Aristolochia fangchi and Stephania tetrandra  
Figure 4.2 shows the HPLC chromatograms of aristolochic acid I and an extract of 
reference Aristolochia fangchi. The peak eluting at 35.7 min (peak 1) was first 
checked by comparing the normalized spectra at the peak upslope, apex and 
downslope. The peak upslope spectrum was subtracted from the apex spectrum to 
eliminate small spectral irregularities arising from the sample matrix, the so-called 
chemical noise. Then the corrected spectrum was compared with the reference AAI 
standard. The match factor was more than 999, which indicates that the spectra are 
similar. The HPLC profiles of roots of Aristolochia fangchi (NICPBP) (Figure 4.2b) 
and Stephania tetrandra (Tongrentang) (Figure 3c) were clearly different. The marker 
compounds, tetrandrine, fangchinoline and AAI, were also successfully identified by 
comparison with the reference chemical standards. In Figure 4.3, the retention times 
of peak1 and peak2 (14.1 and 15.1 min respectively) were comparable to those of the 
chemical standards, fangchinoline and tetrandrine. Their UV match factors were also 
better than 950, indicating that there is high similarity. The UV absorbance of a 
compound might depend on the physical and chemical characteristics of the solvent in 
which the compound is dissolved. For HPLC, this means that the spectrum might be 
dependent on the mobile phase. Therefore, it is strongly recommended that the 
spectrum of reference standard should be obtained under the same condition as the 
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Figure 4.2 HPLC chromatograms of (a) reference standard of AAI and (b) reference 
herb of Guangfangji, and (c) overlaid UV spectra of peak 1 (continuous line) and that 
of AAI (broken line). The RT and UV spectrum of peak 1 in Guangfangji match those 
of AAI.  
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Figure 4.3 HPLC chromatograms of (a) reference standard of tetrandrine, (b) 
reference standard of fangchinoline, and (c) Fangji from Tongrentang, and UV spectra 
match of (d) peak 1 with reference standard of fangchinoline, (e) peak 2 with 
reference standard of tetrandrine. The RT of peaks 1 and 2 in Fangji from 
Tongrentang math those of fangchinoline and tetrandrine respectively. 
























4.3.1.2 HPLC analysis of local Fangji samples 
Using the same chromatographic conditions, the HPLC profiles of the extracts of 10 
local samples of Fangji (or Stephania tetrandra) were compared to those of the 
extracts of the reference herb Aristolochia fangchi (from NICPBP) and that of the 
extract of Stephania tetrandra (from Tongrentang, Beijing). The results were 
intriguing. The HPLC profiles of extracts of 9 local Stephania tetrandra samples were 
found to be similar to that of the reference fangchi. They were clearly different from 
the HPLC profiles of the extract of Stephania tetrandra (Figure 4.4). The HPLC 
profile of the extract of sample 10 was found to be different from those of 
Aristolochia fangchi (Figure 4.4) and Stephania tetrandra (Figure 4.3c).  
The marker compounds of Stephania tetrandra, namely, tetrandrine and fangchinoline, 
could not be found in all the ten herbal samples. Instead, AAI was found to be present 
in all of the local Fangji samples except sample 10. The retention time and UV spectra 
of the suspected peaks were compared with those of the reference standards. 
Retention time of suspected AAI peak was also checked by spiking AAI standard into 
the herbal sample. Figure 4.5 shows the overlaid chromatograms of the sample from 
SINC and the same sample spiked with AAI standard. The suspected AAI peak (peak 
1) has the same retention time with AAI standard. Its UV spectrum also has some 
similarity with that of AA I standard (Figure 4.6). However, the match factor is about 
743, not as high as that of the reference herb, whose match factor is 999.8. This could 
be due to the much lower concentration of AAI in the sample from SINC than that in 
the reference Fangji (Figure 4.6).   
The on-line MS detector offers superiority over DAD detection in term of specificity 
and sensitivity. Thus it is necessary to confirm the presence of AAI in local Fangji 
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samples using MS detection, to provide further evidence that the local Fangji samples 
may be indeed Aristolochia fangchi instead of Stephania tetrandra (i.e. what they 
should be). This is important as Aristolochia fangchi is known to contain toxic 
aristolochic acids.  
4.3.2 LC-MS/MS analysis 
4.3.2.1 Optimization of APCI parameters 
The LC/MS interface parameters were optimized in order to improve sensitivity and 
selectivity. This was done in the positive mode by taking into consideration of the 
vaporizer and the capillary temperature. The influence of the studied parameters on 
the response of the target analytes and the interaction of these parameters were 
evaluated based on the ammonium adduct molecular ion [M+NH4]+ m/z 359 for AAI, 
protonated molecular ion [M+H]+ m/z 623 for tetrandrine and [M+H]+ m/z 609 for 
fangchinoline in the positive mode.  
The heated nebulizer of the APCI interface generates a rapid evaporating mist of 
droplets prior to corona discharge ionization. The spray performance is controlled by 
the vaporizer temperature. The results show that AAI signal is highest when a 
vaporizer temperature is 300°C (Figure 4.7a), while fangchinoline and tetrandrine 
signals are highest when vaporizer temperature is 350°C (Figure 4.7b). However, AAI 
has a much (around 10000 folds) lower signal than tetrandrine and fangchinoline at 
the same concentration (Figure 4.7). Consequently, optimized parameters were based 




Figure 4.4 Overlaid chromatograms of reference Guangfangji, Guangfangji from 
Guangzhou and 10 local Fangji samples (Table 4.1). 














   
 
Figure 4.5 Overlaid chromatograms of Fangji_SINC and that spiked with AAI 
standard. Peak 1 is the suspected AAI peak. (a) and (b) are the enlarged parts of  the 









min0 10 20 30 40 50 
Fangji_SINC 
Spiked with AAI 
Peak 1



























Figure 4.6 (a) Overlaid chromatograms of the extracts of local Fangji sample from 
SINC and that of the reference Guangfangji. (b) Overlaid UV spectra of peak at 35.7 
min of reference Guangfangji (continuous line) and that of AAI (broken line). (c) 
Overlaid UV spectra of peak 1 in Fangji sample from SINC (continuous line) and that 
of AAI (broken line).   













*DAD1, 35.7 of GuangFJ_Ref *AAI 
Match factor: 999.849 
(c)
































































Figure 4.7 Effect of vaporizer temperature on abundance of (a) [M+NH4]+ m/z 359 for 





 After evaporating the solvent in the ionization chamber the analytes reach the first 
vacuum stage via the capillary. While the analytes never reach the set vaporizer 
temperature (due to the evaporation process), the analytes are fully exposed to the 
capillary temperature. Consequently, the thermally labile analytes will be more 
affected by the capillary temperature than by the vaporizer temperature. Figure 4.8a 
shows that AAI signal is best when a capillary temperature is applied at 150°C. In 
Figure 4.8b, higher fangchinoline and tetrandrine signals are achieved when applying 
lower capillary temperature in the range of 125 to 275°C. No lower capillary 
temperature was investigated due to the fact that too low a temperature in some cases 
might be insufficient for keeping the analytes in vaporized state. Thus 150°C was 
chosen as the optimized capillary temperature.  
In order to further improve target ion signals in positive mode, the effect of the tube 
lens offset was also evaluated. From figure 4.9a, it is evident that the value of zero V 
can provide the highest AAI signal. However, as Figure 4.9b shows, there is no much 
influence of tube lens offset on the abundance of fangchinoline and tetrandrine signals. 
Thus, zero V was selected as tube lens offset.  
The achieved optimized instrument APCI parameters were hence vaporizer 












































Figure 4.8 Effect of capillary temperature on abundance of (a) [M+NH4]+ m/z 359 for 
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Figure 4.9 Effect of tube lens offset on abundance of (a) [M+NH4]+ for AAI, and (b) 
[M+H]+ for tetrandrine and fangchinoline  
(b) 
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4.3.2.2 Mass spectra of the reference standards 
In an attempt to obtain mass spectrometric-based information for confirming the 
marker compounds present in the roots of Aristolochia fangchi and Stephania 
tetrandra, direct flow injection experiments of reference standards of AAI, 
fangchinoline and tetrandrine were performed under the optimized APCI conditions.  
In the full scan mode MS spectrum (Figure 4.10a) of AAI, both protonated ([M+H]+, 
m/z 342) and ammoniated ([M+NH4]+, m/z 359) molecules were generated together 
with a fragment ion, [(M+H)-18]+ (m/z 324). The ammoniated molecule ion was the 
base peak. Full product ion spectrum of precursor ion at m/z 359 (the ammoniated 
molecular ion of AAI) was recorded (Figure 4.10b). Protonated molecular ion, 
[(M+NH4)-NH3]+ m/z 342, was generated by loss of ammonia. Further loss of water 
from the precursor ion was very common, so the [(M+NH4)-NH3-H2O]+ (m/z 324) ion 
was found. Another two specific product ions (m/z at 298 and 296) were also 
generated. The [(M+NH4)-44]+ ion due to the loss of carbon dioxide, while the 
[(M+NH4)-46]+ was due to loss of HCOOH. The fragment patterns are in good 
agreement with those previously reported using LC/ESI-MS (Kite et al, 2002). These 
product ions provide useful confirmatory information for AAI.  
In the full scan mode MS spectra of fangchinoline and tetrandrine (Figure 4.11),   
only protonated ions [M+H]+ (m/z 609 for fangchinoline and m/z 623 for tetrandrine 
respectively) were generated. With these protonated molecular ions as precursor ions, 




































Figure 4.10 (a) Full scan mode MS spectrum of AAI; (b) MS/MS spectrum of AAI, 
with precursor ion, [M+NH4]+ m/z 359. 





























































Figure 4.11 Full scan mode MS spectra of (a) fangchinoline and (b) tetrandrine 
 



























   
 
Figure 4.12 MS/MS spectra of (a) fangchinoline with precursor ion m/z 609 and (b) 
tetrandrine with precursor ion m/z 623.  


































































4.3.2.3 LC-MS/MS Analysis of Aristolochia fangchi (NICPBP) and Stephania 
tetandra (Tongrentang) 
Using the optimized APCI method, reference Aristolochia fangchi and Stephania 
tetrandra (Tongrentang) were analyzed. Figure 4.13 shows a typical total ion 
chromatogram (TIC) of reference Aristolochia fangchi (NICPBP, Beijing) (Figure 
4.13a) and related on-line mass spectrum of the peak of AAI with retention time at 
15.21min, obtained in positive ion mode (Figure 4.13b).  The major ions in the full 
scan mode are the ammoniated ([M+NH4]+, m/z 359) and protonated ([M+H]+, m/z 
342) molecules, and a fragment ion, [(M+H)-18]+ (m/z 324). The ammoniated 
molecule was further selected. MS/MS experiment was performed. Figure 4.13c 
shows the chromatogram of product ions of the ammoniated molecule ion. The 
secondary spectrum (Figure 4.13d) shows all the characteristic product ions: m/z 342 
for protonated molecule ion, m/z 324 for the ion due to further loss of water, m/z 298 
for the ion further loss of CO2 and m/z 296 for the ion further loss of HCOOH. The 
full scan mode mass spectrum and MS/MS spectrum are consistent with those of AAI 
standard (Figure 4.10).  
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Figure 4.13 LC/MS/MS analysis of reference Guangfangji: (a) Total ion 
chromatogram (TIC), (b) Full scan mode mass spectrum, (c) Ion chromatogram of 
reference Guangfangji, [M+NH4]+ m/z 359, and (d) MS/MS spectrum. The data agrees 
with MS data from AAI (Figure 4.10), hence confirming the presence of AAI in the 
reference Guangfangji. 
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Figure 4.14 shows a typical TIC of  Stephania tetrandra (Tongrentang, Beijing) 
(Figure 4.14a) and related full scan mass spectra of the peaks of tetrandrine and 
fangchinoline with retention time at 4.9 min and 4.4 min respectively, both obtained 
in positive ion mode (Figure 4.14 b and c).  Only protonated molecular ions were 
detected, m/z 623.3 for tetrandrine and m/z 609.4 for fangchinoline. The protonated 
molecules were further selected. MS/MS experiments were performed. Figure 4.15 
shows the chromatograms of product ions of the protonated molecular ions (Figure 
4.15a and 4.15c). The secondary spectra (Figure 4.15b and 4.15d) show all the 
characteristic product ions. The full scan mode mass spectra and MS/MS spectra are 




Figure 4.14 LC-MS analysis of Fangji (Tongrentang): (a) Total ion chromatogram, (b) 
Mass spectrum of peak at 4.9 min, and (c) mass spectrum of peak at 4.4 min. The MS 
data agrees with those of the standards fangchinoline and tetrandrine (Figure 4.11), 
hence confirming the presence of these two standards in the extract of Fangji 
(Stephania tetrandra) from Tongrentang. 
 




























































































































































Figure 4.15 LC-MS/MS analysis of Fangji (Tongrentang): (a) ion chromatogram, 
m/z 609; (b) MS/MS spectrum in full scan mode, precursor ion m/z 609; (c) ion 
chromatogram, m/z 623; and (d) MS/MS spectrum in full scan mode, precursor ion 
m/z 623. The data agrees with those obtained from the fangchinoline and tetrandrine 
standards (Figure 4.11 and 4.12), hence confirming the presence of these 2 standards 
in the extract of Fangji (Tongrentang). 
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4.3.2.4 LC-MS/MS analysis of local samples 
In the previous section (4.3.1.2), HPLC analysis indicated that 9 of the 10 local Fangji 
samples may be Aristolochia fangchi instead of the expected Stephania tetrandra. 
AAI was found to be present in all but 1 of the local Fangji samples; while tetrandrine 
and fangchinoline were not found in any of them. Figure 4.16a shows a typical total 
ion chromatogram of local Fangji sample. The fall scan mode mass spectrum of peak 
at 15.14min (Figure 4.16b) exhibited the characteristic ammoniated molecular ion, 
m/z 359 ([M+NH4]+),  protonated ion, m/z 342 ([M+H]+) and a fragment ion at m/z 
324 ([(M+H)-H2O]+). Figure 4-16c shows the ion chromatogram with precursor ion 
m/z 359. The secondary spectrum of peak at 15.07 min shows the characteristic 
product ions, m/z 342 ([(M+NH4)-NH3]+), m/z324 ([(M+NH4)-NH3-H2O]+), m/z 198 
([(M+NH4)-NH3-CO2]+), and m/z 296 ([(M+NH4)-NH3-HCOOH]+). The content of 
AAI in these samples are at trace level, not as much as that in the reference 
Aristolochia fangchi (NICPBP, Beiing) (Figure 4.13). These results are consistent 















































   












































Figure 4.16 LC-MS/MS analysis of a typical local Fangji sample (no 3). (a) Total ion 
chromatogram; (b) full scan mode mass spectrum of the peak marked as arrow in (a) ; 
(c) ion chromatogram, m/z 359; and (d) MS/MS spectrum of the peak marked as 




The HPLC-DAD and LC/MS methods developed are suitable for the differentiation of 
Stephania tetrandra (Fangji) and Aristolochia fangchi (Guangfangji). Ten herbal 
samples bought as Fangji (or Stephania tetrandra) were analyzed by these methods. 
In nine of the ten herbal samples, AAI was detected by HPLC-DAD and confirmed by 
LC/MS/MS. In addition, the marker compounds of Stephania tetrandra 
(fangchinoline and tetrandrine) were not detected in any of these 10 samples. The 
evidences indicate that the nine samples bought locally are Aristolochia fangchi 
instead of Stephania tetrandra. This case has been reported to Health Sciences 
Authority. Further work need to be done to further elucidate the identity of the sample 
(sample 8) that did not appear to resemble Aristolochia fangchi or Stephania 
tetrandra.  
 Most of the herbs bought in Singapore under the name of Fangji (Stephania tetrandra) 
were found to contain the toxic aristolochic acid I, and not the expected tetrandrine 
and fangchinoline. This study underscores, once again, the necessity of the 








Chapter 5 Conclusion 
Analysis of complex mixtures of botanical origins is very challenging. The work 
presented in this thesis has clearly demonstrated that methods for the analysis of some 
commonly used herbs in Singapore and around the region, have been developed and have 
been shown to be useful for the quality control of such botanicals and their products. The 
methods developed can be extended to other complex mixtures of botanical origins with 
appropriate optimization, when necessary. 
Chapter 1 gives a general introduction to the importance of herbal medicine, the 
increasing need for quality control and highlights some common analytical methods used 
for quality control of herbal medicine. The specific objectives are also stated, namely, to 
develop methods for the analysis of G. elata and its products; for chromatographic 
fingerprinting of 11 different commonly used herbs and finally, for differentiating 
between 2 plants with the same common name, both available locally but one of which is 
toxic. 
In Chapter 2, a rapid and sensitive HPLC method for the detection of 4 biologically 
active chemical markers in G. elata, namely, gastrodin, 4-hydroxbenzyl alcohol and 4- 
hydroxybenzaldehyde and L-pyroglutamic acid has been successfully developed. To the 
author’s knowledge, this is the first report of simultaneous detection of 4 active 
constituents in this medicinal plant. The contents of gastrodin, which is the main active 
ingredient, hasve also been determined in the plant and in CPM products. This method 
has been validated for linearity, precision, accuracy, LOD and LOQ. For the CPM, the 
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presence of other plants resulted in the gastrodin peak being co-eluted with other herbal 
ingredients. Hence a SPE sample cleanup is successfully developed and employed. 
Chapter 3 addresses the usefulness of chromatographic fingerprinting in the 
differentiation of commonly used herbs. The HPLC chromatographic fingerprint can be 
used for quality control of herbal medicines, especially when the marker compounds are 
not available. In the present work, a HPLC chromatographic fingerprinting method is 
successfully developed and applied to 34 botanical samples, constituting 11 different 
types of herbal medicine. Hierachical analysis yields interesting results. 4 herbs (namely, 
Madouling 马兜玲, Huangqin 黄芩, Tianma天麻 and Banxia 半夏) give distinctive and 
consistent chemical fingerprints. Differences between the same herbs from different 
sources have been detected for botanicals such as Duzhong (杜仲) and Banlangen (板蓝
根). The results for the “Fangji”, Guangfangji (广防己) and Hanzhongfangji (汉中防己) 
samples indicate possible misidentification / substitution and deserve further 
investigations. For complex mixtures that are not well resolved in this general protocol, 
clearly, further optimisation of the method is necessary. This is evident from the similar 
chemical fingerprints of the extracts of Shengdi (生地) and Shudi (熟地). The latter is 
essentially the steamed form of the former. 
HPLC-DAD has been proven to be a useful tool for identification of marker compounds 
in herbal medicines, based on its ability of providing three-dimension information: 
retention time and UV spectrum. Eight biologically active compounds are employed as 
biomarkers and are screened in these herbal samples. Aristolochic acid I (AAI), a 
nephrotoxic component of Guangfangji, is found in the local Fangji samples. 
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Liquid chromatography with mass spectrometry/mass spectrometry detection (LC-
MS/MS) offers superiority over HPLC-DAD in terms of specificity. The secondary MS 
spectrum can provide confirmatory information. HPLC-DAD and LC-MS/MS methods 
have been further developed for differentiation of 2 medicinal plants, namely Fangji 防己 
(Stephania tetrandra) and Guangfangji 广防己  (Aristolochia fangchi) in Chapter 4. 
Tetrandrine and fangchinoline, bioactive components of Stephania tetrandra, and 
aristolochic acid I (AAI), a nephrotoxic component of Aristolochia fangchi, are 
successfully used for differentiation of these two herbs. Using these techniques, 9 out of 
10 local herbal samples bought as Fangji (Stephania tetrandra) are found to be the toxic 
Aristolochia fangchi instead.  Fangchinoline and tetrandrine, the marker compounds of 
Stephania tetrandra, are not detected in them, while AAI is found to be present in most 
of these samples. The Health Sciences Authority has been informed of this finding. This 
study also indicates the urgent need for greater quality control of natural products. It is 
hoped that through the cooperation of academia, researchers, regulators, practitioners, 
patients, and the industry, the benefits of botanical products can be exploited while 
reducing risks of toxicity or adverse reactions. 
The bioactive components can be potentially used as markers for quality control of herbal 
medicines. However, in most cases, the bioactive components of a herb used as markers 
may not reflect the efficacy of the whole herb. As new bioactive constituents are isolated, 
the analytical methods need to be updated too. The components of the herbs from the 
same species can usually have some similarity. For example, aristolochic acids are the 
common components of many herbs from the family of “Aristolochia”, such as 
Aristolochia fangchi (Guangfangji 广防己), Aristolochia recurvilabra (Qingmuxiang 清
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木香) and Aristolochia manshuriensis (Guanmutong 关木通). In such a case, aristolochic 
acid alone as marker is not enough to indicate the authenticity of the herb. Other methods, 
such as chromatographic fingerprinting, DNA fingerprinting, need to be further 
developed. Future work can involve a combination of these techniques and obtaining 
samples from the sources of origin (i.e. from the plantations). 
Herbal medicines continue to be widely used by people throughout the world. The usage 
is increasing rapidly and this has important medical and socio-economic implications. 
Assessment of the safety, quality and efficacy of herbal medicines is an important issue 
for health professionals and regulators. Academics/researchers, health professionals, 
consumers, regulators and people from industries must work together to ensure the safety 
and quality of herbal medicines. 
The entire process of quality control of medicinal plants and their products should 
involve good agricultural practice, good storage /supply practices and good 
manufacturing practice etc. More collaborative research work needs to be done to 
establish a good and feasible quality control framework. This framework should include 
guidelines endorsed by international organisations such as WHO; appropriate policies 
adapted to the specific requirements of herbal medicines and regulated by the regulatory 
agency in each country and be followed by the farmers/suppliers/manufacturers, to 
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